分类： cc

Why do Wang Jianlin and Wanda executives frequently appear in Xishuangbanna, Yunnan？

The past 72 hours have been the first weekend in which the Wang Jianlin family has returned to the throne of China’s richest man at 170 billion and surpassed Li Ka-shing to become the richest Chinese in the world for the first time. When Wang Jianlin flew to Europe to visit Oxford, buy and buy, and meet French President Fran?ois Hollande, his Wanda played another big game in Xishuangbanna, Yunnan Province, at home.

It snowed again this weekend in Beijing, but in Xishuangbanna, it was a pleasant time with high clouds and a temperature of 24 degrees. In Jinghong, the capital of Xishuangbanna, with beautiful mountains and rivers and rich Dai flavor, Gong Xiaowen, assistant president of Wanda Group and deputy general manager of the cultural and tourism project management center, and a group of Wanda executives all donned local ethnic costumes and kicked off a big party.

It is said that the painting style at the scene is like this:

Why do Wang Jianlin and Wanda executives frequently appear in Xishuangbanna, Yunnan?

Why do Wang Jianlin and Wanda executives frequently appear in Xishuangbanna, Yunnan?

Why do Wang Jianlin and Wanda executives frequently appear in Xishuangbanna, Yunnan?

Why do Wang Jianlin and Wanda executives frequently appear in Xishuangbanna, Yunnan?

Why do Wang Jianlin and Wanda executives frequently appear in Xishuangbanna, Yunnan?

You are wrong to think that this is just a beauty pageant. While the beautiful women are on stage to perform and canvass votes, the judges sitting under the stage are the bosses of the top 100 real estate distributors in China. It is said that everyone loves beauty and it is obvious, such as the one in the picture below:

Why do Wang Jianlin and Wanda executives frequently appear in Xishuangbanna, Yunnan?

But making money with the richest man is the true OS of those who are in business.

Why do Wang Jianlin and Wanda executives frequently appear in Xishuangbanna, Yunnan?

In addition to selecting a few splashing beauties, the distributors’ real ambition is to get a share of a cultural tourism market developed by Wanda in the southwest. Wanda Xishuangbanna International Resort – is the third large-scale cultural tourism project launched by Wanda Group after Changbai Mountain Resort and Wuhan Central Cultural District. After officially opening to the public on September 26, 2015, as of the first month of the Year of the Monkey, it has received more than 350,000 visitors. During the Spring Festival holiday, Wanda’s sales center welcomed more than 4,000 visitors and inquiries, and sold 300 suites. Follow the richest man to eat meat!

Compared with the more eye-catching tourist destinations in Yunnan that have been commercially developed on a large scale, such as Dali and Lijiang, why is Xishuangbanna, which has been stuck in people’s minds almost solely on the TV series "Sin" in the 1990s, so popular? How could I tell you that the picture below is Xishuangbanna Street during the Spring Festival, not the "parking lot" of the Third Ring Road of the Imperial City! (The tail numbers of the vehicles are all Yun A, Yu B and Sichuan A)

Why do Wang Jianlin and Wanda executives frequently appear in Xishuangbanna, Yunnan?

More than 90 distributors in 26 cities had signed up for the Wanda Xishuangbanna project by the end of the global distributor conference, according to the latest data. On Wednesday and Thursday in the past week, 11 and 7 other homes were sold respectively. It is not uncommon for customers in the three southwestern provinces with the highest awareness of Xishuangbanna and in Beijing to buy by air in droves, and the phenomenon seen in the Wanda project alone is that the proportion of hand-holding is quite high.

Why do Wang Jianlin and Wanda executives frequently appear in Xishuangbanna, Yunnan?

The richest man who is not short of money has invested 16 billion yuan with a wave of his hand. Today’s Wanda Xishuangbanna International Resort has become the largest and highest-level cultural tourism project in Southwest China. Those who have seen the Wanda Han Show in Wuhan can probably imagine what kind of visual enjoyment and cultural tourism senses the Dai Show in Xishuangbanna will bring. After the completion of Wanda Xishuangbanna International Resort, China has a cultural industry that can rival Disney in the United States.

Why do Wang Jianlin and Wanda executives frequently appear in Xishuangbanna, Yunnan?

Why do Wang Jianlin and Wanda executives frequently appear in Xishuangbanna, Yunnan?

Do not go abroad to enjoy the South East Asia style – theme park, Dai show theater, bar street, Wanda Plaza, six-star hotel group, one-stop education with ring, tier 1 hospital and other seven formats readily available, from the land to the opening, vigorous Wanda used only four years. Gong Xiaowen, wearing Dai clothes, said proudly at the distributor conference that in 2015 Wanda Xishuangbanna International Tourist Resort has received 21 million domestic and foreign tourists, and the increase in passenger flow has fully surpassed the traditional hot spots in Yunnan Lijiang and Hainan Sanya.

Why do Wang Jianlin and Wanda executives frequently appear in Xishuangbanna, Yunnan?

How significant is Xishuangbanna in the Wanda system? Three things can illustrate the problem.

First, Wanda set the 2015 annual meeting in Xishuangbanna, and all Wanda employees flew to Caiyun South. And this year, Wanda employees’ annual leave benefits are to bring their families to Xishuangbanna for vacation.

Second, the richest man usually walks the mall without a smile, but on the evening of January 16, Wang Jianlin made his debut in Xishuangbanna to vent his self for the first time, presenting a cover of "False Walking Monk" at the level of a Chinese good voice. The rock style is not inferior to the original singer Cui Jian, and the audience is very popular on the Internet.

Why do Wang Jianlin and Wanda executives frequently appear in Xishuangbanna, Yunnan?

Third, Wang Jianlin has repeatedly claimed in internal meetings that by 2018, Banna will be "hard to find a room". The overbearing president has spoken out, and Wanda has put this southwest cultural tourism market on the top agenda of the group. In addition, what he has gone to Europe to buy these days is actually a cultural tourism project. Wanda, which once relied on Wanda Plaza and Wanda Cinema to make its name in China, could not be more clear about its intention to turn the bow and go to the blue ocean of culture and tourism.

Why do Wang Jianlin and Wanda executives frequently appear in Xishuangbanna, Yunnan?

Wanda’s fourth transformation attempt to go real estate, in the world’s largest movie theater chain, the world’s largest sports industry, the world’s largest children’s entertainment enterprises, the world’s largest five-star hotel, the world’s largest tourism enterprises on the road, Xishuangbanna International Tourism Resort, is a very typical significance of the key.

It can be said that Xishuangbanna has become the international Banna and Wanda’s Banna. Before he had the ability to build high-rise buildings on the ground, Wang Jianlin had already opened up the wealth appreciation channel of Xishuangbanna. The ethnic minorities and exotic customs that have not been fully tapped by the outside world have made Xishuangbanna an investment depression. It is also the southwest gate of China on the international stage. After the opening of the Pan-Asian High-speed Railway in 2018, it will take only two hours from Kunming to Xishuangbanna, and only four hours to Thailand.

Why do Wang Jianlin and Wanda executives frequently appear in Xishuangbanna, Yunnan?

The richest man has such capabilities – the railway station is only a five-minute drive from the Wanda scenic spot, which means that Xishuangbanna’s future reception capacity will multiply exponentially.

What makes Xishuangbanna special ahead of tourist resorts such as Sanya is that Xishuangbanna has unparalleled geographical and religious and cultural advantages. A Lancang River, adjacent to the borders of six countries in South East Asia, and under the unique religious background such as pan-Asian and southern Buddhist holy places, there is huge room for international tourists to rise. Not long ago, on February 18, the South East Asia Buddhist event – the Southern Buddhist Monk Ascension Ceremony Ceremony was just held in Xishuangbanna, and Wanda took part of the reception work at that time.

Why do Wang Jianlin and Wanda executives frequently appear in Xishuangbanna, Yunnan?

It is not hard to see why, when Wang Jianlin decided to invest in Xishuangbanna, local government officials attended the signing ceremony and almost greeted him with their hands and feet raised – Wanda has become a coveted business card of Xishuangbanna and southwest China’s trade gate.

Nowadays, the room rate of Wanda Xishuangbanna Hotel is as high as 70%, and the price of Wanda Wenhua Hotel in the resort area has risen to more than 4,000 yuan/night during the Spring Festival. The richest man has decided to build two more five-star hotels in addition to Wanda Wenhua, Wanda Hilton DoubleTree and Wanda Crowne Plaza.

Why do Wang Jianlin and Wanda executives frequently appear in Xishuangbanna, Yunnan?

With the strong sales capacity of the Spring Festival, Wanda Xishuangbanna International Tourist Resort project has jumped to the top of Yunnan congeneric product sales. With China’s 100 savviest distributors hoping to make a fortune with Wanda, it is no surprise that this distributor conference will be the highest-profile and most attended event ever – no wonder the leaders of Wanda and exclusive e-commerce partner NetEase can laugh so happily in front of the splashing beauty.

Why do Wang Jianlin and Wanda executives frequently appear in Xishuangbanna, Yunnan?

Liu Yunlong Fan Bingbing ＂Dongfeng Rain＂ is talented and plays various musical instruments


Liu Yunlong, Fan Bingbing


Fan Bingbing was kidnapped


Fan Bingbing plays the flute, Liu Yunlong plays the piano


Fan Bingbing and Liu Yunlong are perfect partners

　　In the upcoming movie "Dongfeng Rain" on April 21, the pianist "An Ming" played by Liu Yunlong transmits information in a mysterious way, and the singer "Huanyan" played by the female lead Fan Bingbing, as the "queen of songs" of Xianlemen, hides her identity with her singing and dancing. Little do they know that the Xianlemen Club, a place of intoxication and flashy dreams, has become a talent show for Liu Yunlong and Fan Bingbing outside the play. The two of them also played the song "Qin Di and Ming" and performed a classic bridge section of the time-travel version of "Xiaoao Jianghu".

Liu Yunlong: Practice the piano, grab musical instruments, and dance

　　In the film, Liu Yunlong plays the pianist An Ming. Director Liu, who has learned piano in his early years, will show his piano skills in the film. In this regard, Director Liu is unequivocal, and every time there is an "An Ming" piano play, he must play in person. From time to time, the music of the etude comes from the stage on the set, and it turns out that Director Liu has practiced the piano again. Whenever there is a play by others, Director Liu will run to the piano with an itch, under the guise of "supervision", and stare at others. In fact, he will take the opportunity to learn secret techniques desperately, like a "curious baby" question thrown one after another.

　　In addition to the piano, Director Liu seemed to be addicted to playing musical instruments, often grabbing other people’s musical instruments to play. After a while, I saw him raise the violin on his shoulder, ignoring the timbre, the posture was absolutely elegant. After a while, I saw him resting in front of the drum set and banging hard, passionate, this curious baby’s eagerness to learn always makes people laugh and cry.

　　In addition to the musical instrument, seeing Fan Bingbing lift his skirt and practice dancing on the spot, Director Liu couldn’t help but "say goodbye" to him. He saw Director Liu hand in hand with his dance partner – the wooden flag dragon who plays "Shinichi Yano" in the film, walking to the dance floor. As the music sounded, the two twisted for a while and played happily. Director Liu, the "decathlon", also frequently "provoked" Fan Bingbing with his eyes, which was quite hilarious.

Fan Bingbing: Singing old songs, performing dance plays, playing the flute

　　Seeing Director Liu playing various musical instruments, Fan Bingbing did not show any weakness. In the film, playing the singer "Huanyan", she not only has to perform many arias in person, but also sing the classic song "When Will You Come Again", and will also challenge the musical and dance for the first time, facing the dual challenges of song and dance skills. In the play, she has a variety of styles, and outside the play, Fan Bingbing is equally versatile. On the set, she also picked up the flute that she had not touched for many years, and played a tune with Director Liu.

　　Under the performance of a professional symphony orchestra, Fan Bingbing’s "Huanyan" was dressed in a pocket top hat and a black dance dress, lying on the piano, which was particularly enchanting. During the intermission, Fan Bingbing couldn’t help itching, borrowed the orchestra’s flute, and played a song in the middle of the dance floor. Although he hadn’t practiced for many years, Fan Bingbing’s posture and skills were unequivocal, and even the orchestra conductor couldn’t help but praise it. His gestures were in place, and his skills were extremely solid. I saw her standing in the center of the performance stage, playing the flute, and Director Liu of "Aegean Enchant" could not help but say that he took the initiative to match the piano, and the two also made eye contact from time to time, which was very similar to the classic bridge in the "Xiaoao Jianghu" version – Linghu Chong and Ren Yingying’s Qin Xiao ensemble.

Luxin Venture Capital： Dig deep into ＂Moments＂ and introduce ＂hard technology＂

　　The ecosystem built by technology and products of technology enterprises is profoundly changing life scenes and industrial patterns. In the current era of accelerating towards intelligence, innovative technology ecology has increasingly become a key element for the transformation of old and new kinetic energy and the high-quality development of industries.

　　Technology ecosystem refreshes smart experience

　　What kind of intelligent experience can a technology ecosystem bring?

　　Driving a smart car, encountering complex traffic scenarios such as road construction obstacles, pedestrians crossing the road, and suddenly appearing electric vehicles, can identify dangers earlier and faster, easily change lanes to avoid obstacles, actively avoid risks, and actively stop.

　　Using a smart PC, you can quickly and accurately extract key information from text, audio, and video content without time and effort;

　　Open the smart screen and point to the remote control to make the control as convenient as playing with a mobile phone;

　　Wearing smart earphones, you can automatically switch the noise reduction mode according to the environment without hands, and smart watches and smart bracelets can detect health indicators and generate micro-physical examination reports;

　　Install the smart door lock, no matter the light is bright or dark, the angle and distance change can be accurately and securely unlocked by facial recognition…

　　The most important thing is that all these products can achieve synergy, such as mobile phones can be remotely parked, watches can be used as car keys, mobile phone applications can be "touched" to the car screen, smart screen, and even smart door locks can be linked with mobile phones, smart screens, and other multi-screens.

　　This is the full scenario of the Internet of Everything showcased at Huawei Hongmeng Ecological Spring Communication Conference on April 11. The underlying distributed capabilities of Hongmeng Ecological can achieve full-scene device collaboration, allowing smart experiences to pervade all aspects of people’s lives.

　　"Since January 18 this year, Huawei announced that the first batch of more than 200 application manufacturers are accelerating the development of Hongmeng native applications. By the end of March, there will be more than 4,000 applications, and the growth rate will be as high as 20 times in just two months, covering more vertical applications." Yu Chengdong, executive director of Huawei, CEO of end point BG, and chairperson of smart car solutions BU, revealed at the communication meeting that Hongmeng ecology has achieved a complete vertical industry coverage, including convenient life, travel and tourism, financial management, social information, productivity tools, corporate office, audio and video entertainment. Applications in various fields are competing to start Hongmeng native application development, constantly injecting new vitality into Hongmeng ecology.

　　Among them, it is particularly worthy of attention that Huawei, which "does not build cars", is helping more car companies to "build good cars": with more than 30 years of technical accumulation in the ICT field, it has shown obvious advantages through Hongmeng Zhixing ecology to help the commercial success of automotive industry partners. Taking the Q Jie jointly built by Huawei and Sailis as an example, the number of phenomenon-level explosive models Q Jie’s new M7 is set to reach 174,000 in 7 months; the full-scene smart flagship SUV Q Jie M9 has been listed in just three months. A total of 70,000 vehicles have been set to break through, breaking the domestic 500,000 yuan level luxury car sales speed record. In the first quarter of this year, the cumulative sales of the new M7 reached 74,400 units, winning the first place in the sales of single models of new forces in China.

　　"If China wants to build a good car, it cannot do without Huawei. If China wants to go from an automobile power to an automobile power, it needs the empowerment of Huawei Hongmeng System." Yin Tongyue, secretary of the party committee and chairperson of Chery Holding Group Co., Ltd., said at the communication meeting. When talking about the S7 smart car of Hongmeng Zhixing, which Chery has cooperated with Huawei, Yin Tongyue said that the smart world is Chery’s most important project. Chery has become an independent business unit of the Lizhijie brand, led by the R & D leader and the manufacturing leader, and the exclusive manufacturing industrial production line and special project resources are guaranteed.

　　This is Huawei’s booth at the 4th China International Consumer Goods Expo, where Hongmeng ecological products, including Hongmeng Zhixing, are on display. Photo by Yang Guanyu, a reporter from Xinhua News Agency

　　Full scene artificial intelligence deeply empowered

　　From smart travel to smart home, from smart office to smart wear, Hongmeng’s new products are packed with various innovative technologies, among which AI (artificial intelligence) is undoubtedly a high-frequency word.

　　One of the biggest highlights of the new Huawei MateBook X Pro laptop released at the Hongmeng Ecological Spring Communication Conference is its thinness, with a thickness of only 13.5 mm and a weight of only 980 grams. According to Yu Chengdong, the MateBook X Pro is the only notebook equipped with Intel Core Ultra 9 high-performance processor within 1kg, and it is also the world’s first 14.2-inch flexible OLED notebook. More notably, this is the first time that Huawei PC has applied Huawei Pangu model. Its AI summary function can quickly and accurately extract key information from text, audio and video content. In addition, the MateBook X Pro is also equipped with Huawei AI space function for the first time. Through this one-stop AI ability aggregation entrance, it can make code programming, PPT production, paper reading and typesetting, collection of learning materials, video picture creation, travel planning and other scenes more efficient and convenient. On this heavyweight AI PC, Huawei also jointly tuned with Wanxing Meow Shadow to call NPU for AI special effects creation, bringing users a smarter and more efficient experience; in cooperation with WPS, it brings a series of AI functions including text intelligent typesetting, dialogue operation tables, and brain map-to-PPT.

　　It is understood that the AI capabilities of the Pangu model have been mainly used in the industry before. This move on the PC track will be an important step in the exploration of the Pangu model on the consumer side, and the on-board smart assistant Xiaoyi will also be connected to the Huawei Pangu model in May.

　　In fact, not only is there a big model blessing, but the new products of Hongmeng Ecological all scenes are deeply empowered by AI technology. For example, behind the staggering smart driving capabilities of the Smart World S7 is Huawei’s rich scene library built on the AI training cluster, in which more than 12 million kilometers of simulation tests are carried out every day, and the learning and training computing power reaches 3.3E FLOPS (tens of billions of floating-point operations per second). The model update speed is iterated every 5 days, and the intelligent driving ability is continuously iterated and upgraded with massive data; the AI camera equipped with Huawei’s smart screen has powerful intelligent perception capabilities, which can realize 3D bone recognition, sitting posture or distance reminders, portrait tracking, etc.; Huawei Smart Door Lock Plus applies self-developed AI technology to 3D facial recognition, which not only independently learns subtle changes in the face and environment, but also has powerful AI 3D anti-counterfeiting detection, and can resist photos, videos, masks Five attack methods, such as headgear and 3D headmold, ensure that facial recognition is more convenient, safer and smarter from the bottom of the technology.

　　Accumulate new potential energy to open up more space

　　With this year’s "artificial intelligence +" being written into the government work report for the first time, artificial intelligence is expected to deeply empower the development of the real economy and become an important engine for the development of new quality productivity. At the application level, artificial intelligence is deeply integrated with all walks of life, and is expected to build a data-driven, man-machine collaboration, cross-border integration, and co-creation and sharing of intelligent economic forms, giving birth to new economic growth points.

　　Take the PC industry as an example. The industry generally believes that AI PCs will reshape users’ PC experience, profoundly change people’s work patterns and lifestyles, improve the efficiency of the whole scene, and set off a new round of PC replacement.

　　IDC, a market research firm, reports that the proportion of AI PCs installed in China’s PC market will only be 8.1% in 2023, and the proportion will increase significantly to 54.7% in 2024. It is expected to rise rapidly in the next few years, reaching 85% in 2027 and becoming the mainstream of the PC market.

　　Huaxin Securities Research Report said that the AI PC usage scenarios are highly overlapping with the application scenarios currently covered by the AI big model, and are called "the best carrier of the big model." Chip processor manufacturers such as Qualcomm, AMD, and Intel have launched processors for AI PCs.

　　Industry insiders believe that the launch of AI PC products by the top end point brand marks the arrival of the AI PC era. At present, Apple, Microsoft and other tech giants have released AI PCs. As the top three manufacturers in the domestic PC market and the only one growing against the trend, Huawei’s entry into the new AI PC track will help the recovery of the PC industry chain and is expected to add new vitality to the PC industry.

Announcement of Shenzhen Listed Companies (March 8)

　　Cylon Pharmaceuticals: Subsidiary Receives Approval for Pregabalin Listing Application

　　() Announcement: Hunan Sailong Pharmaceutical Co., Ltd., a wholly-owned subsidiary, has recently received the approval of Pregabalin’s "Notice of Application for Marketing of Chemical APIs" issued by the State Drug Administration.

　　Cylon Pharmaceutical: Subsidiary Receives Approval of Pregabalin Chemical API Listing Application

　　On March 7, Cylon Pharmaceutical announced that its subsidiary had received approval for the listing of Pregabalin chemical raw materials.

　　Cylon Pharmaceutical: Subsidiary Received Notification of Approval for the Listing Application of Pregabalin, a Chemical API

　　Sailon Pharmaceutical announced on the evening of March 7 that Hunan Sailon Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, has recently obtained the approval of pregabalin "Chemical API Marketing Application Approval Notice" issued by the State Food and Drug Administration. The main indications of pregabalin are: for the treatment of post-herpetic neuralgia and fibromyalgia.

　　Cylon Pharmaceutical: Subsidiary chemical raw material drug "pregabalin" was approved for listing

　　Sailong Pharmaceutical announced that Hunan Sailong Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, has recently obtained the "Notice of Approval for the Marketing of Chemical API" approved by the State Drug Administration. It is reported that the main indications of pregabalin are: for the treatment of post-herpetic neuralgia and fibromyalgia.

　　Lisheng Pharmaceutical: Ticagrelor API passed the marketing application

　　() Announcement: The company has received the "Notice of Approval of Application for Listing of Chemical APIs" issued by the State Drug Administration for ticagrelor APIs, and the variety has passed the application for listing of chemical APIs.

　　Garden Bio completed the repurchase of 1.69% of the shares, costing 100 million yuan

　　() announcement, as of March 6, 2024, the company through the share repurchase special securities account to the centralized auction transaction to repurchase the company’s shares 9.3072 million shares, accounting for 1.69% of the company’s current total share capital, the minimum transaction price is 10.09 yuan/share, the highest transaction price is 11.83 yuan/share, the total transaction amount is RMB 100 million yuan (including transaction costs). The company’s repurchase has been completed, the actual repurchase time range is September 14, 2023 to March 6, 2024.

　　The shareholders’ meeting will be held on March 22 to consider the company’s proposal to apply for a project loan from the bank as collateral for its own assets

　　Rifeng shares announced that the third extraordinary general meeting of shareholders will be held on March 22, 2024, and the online voting will be held on the same day. The equity registration date is March 15, and investors who hold Rifeng shares after the market closes on that day can participate in the voting.

　　Meeting place: Conference room on the first floor of Guangfeng Industrial Park Company, West District, Zhongshan City.

　　The shareholders’ meeting audited a total of one proposal, as follows:

　　1. Proposal on the company applying for a project loan from the bank with its own assets as collateral.

　　ST plans to sell a 17% stake in CCCC New Energy and optimize its investment structure

　　() Announcement, the company plans to transfer the 17% equity of Jiangsu CCCC New Energy Technology Co., Ltd. (referred to as "CCCC New Energy") held by its wholly-owned subsidiary Nanjing Keshu Technology Co., Ltd. (referred to as "Nanjing Keshu") to Lu Yicheng at a price of 40 million yuan. After the transfer is completed, Nanjing Keshu will no longer hold the equity of CCCC New Energy.

　　The announcement said that the company’s current main business is cross-border e-commerce export, and its long-term development strategy in the future lies in focusing on strengthening core business capabilities and further strengthening and refining the main business of cross-border e-commerce. In order to further protect the company’s ROI, optimize the company’s investment structure, and improve the asset quality and profitability of listed companies, the company has decided to transfer the equity of CCCC New Energy.

　　Jujie Microfiber: The controlling shareholder intends to increase its holdings by 15 million yuan – 30 million yuan

　　() Announcement that the controlling shareholder Suzhou Jujie Investment Co., Ltd. intends to increase its holdings by not less than 15 million yuan and not more than 30 million yuan.

　　Jujie Microfiber: The controlling shareholder of the company plans to increase its holdings by 15 million yuan – 30 million yuan

　　On March 7, Jujie Microfiber announced that the company’s controlling shareholders plan to increase their holdings by 15 million yuan – 30 million yuan.

　　Jujie Microfiber’s controlling shareholder plans to spend 15 million yuan to 30 million yuan to increase shares

　　Jujie Microfiber announced that the controlling shareholder of the company, Suzhou Jujie Investment Co., Ltd. (referred to as "Jujie Investment", "the main body of the increase") plans to increase its holdings of the company’s shares within the next 6 months from the date of this announcement through the means allowed by the China Securities Regulatory Commission and the Shenzhen Stock Exchange trading system (including but not limited to centralized bidding and block trading, etc.), with a total amount of not less than RMB 15 million yuan and not more than RMB 30 million yuan.

　　Dong Chunhong, supervisor of Tuoxin Pharmaceutical, has reduced his holdings by 1,000 shares

　　() announcement, the company received the "notice letter on the expiration of the implementation time of the share reduction plan and the result of the reduction" issued by director Qu Guirong and supervisor Dong Chunhong respectively. As of the date of issuance of the notice letter, director Qu Guirong and supervisor Dong Chunhong reduced their holdings by 0 shares and 1000 shares respectively through centralized bidding transactions, and the implementation time of the reduction plan has expired.

　　(): It is planned to purchase 100% equity of Hunan Persimmon Bamboo Garden Nonferrous Metals Co., Ltd. by issuing shares and paying cash

　　China Tungsten High-tech announced that the company intends to purchase the 100% equity of Hunan Persimmon Bamboo Garden Nonferrous Metals Co., Ltd. jointly held by Minmetals Tungsten Industry Group Co., Ltd. and Hunan Woxi Mining Investment Co., Ltd. by issuing shares and raising supporting funds to no more than 35 specific investors. This reorganization is expected to constitute a major asset reorganization as stipulated in the "Measures for the Administration of Major Asset Restructuring of Listed Companies", and also constitutes a company related transaction. This reorganization does not constitute a reorganization and listing. This transaction will not lead to a change in the actual controller of the company.

　　The shareholders’ meeting will be held on March 26 to consider the proposal to acquire all the shares of Zhengzhou Jimei by cash and related party transactions

　　Langzi shares announced that the first extraordinary general meeting of shareholders will be held on March 26, 2024, and the online voting will be held on the same day. The equity registration date is March 14, and investors who hold Langzi shares after the market closes on that day can participate in the voting.

　　Meeting place: 16th Floor Conference Room, Building 1, Courtyard 3, Dajiaoting South Street, No. 27, Xidawang Road, Chaoyang District, Beijing (Langzi Building).

　　The shareholders’ meeting audited a total of one proposal, as follows:

　　1. Proposal on the cash acquisition of all the shares and related transactions of Zhengzhou Jimei.

　　Henghui Security: the actual 3.76 million shares will be listed on March 11

　　() Issue a prompt announcement on the partial lifting of the restrictions on the sale of the issued shares before the initial public offering and listing for circulation. The number of restricted shares listed and circulated this time is 10 million shares, accounting for 6.8693% of the company’s total share capital. The actual number of shares that can be listed and circulated is 3.76 million shares. The listing and circulation date is March 11, 2024 (Monday).

　　Liangxin plans to invest 26 million yuan in a holding subsidiary to promote the development of intelligent power distribution business

　　() Announcement, the company intends to jointly invest with Shanghai Zhuyong Enterprise Management Partnership (Limited Partnership) (abbreviation: "Zhuyong Enterprise"), Shanghai Zhuyong Enterprise Management Partnership (Limited Partnership) (abbreviation: "Zhuyong Enterprise"), Shanghai Zhuzhi Enterprise Management Partnership (Limited Partnership) (abbreviation: "Zhuzhi Enterprise") to establish Liangyun Zhihui (Guangdong) Co., Ltd. (tentative name, the final name shall be subject to the name approved by the registration authority, abbreviation: "Joint Venture Company"). The registered capital of the joint venture company is tentatively 50 million yuan, of which the company’s capital contribution is 26 million yuan, and the shareholding ratio is 52%. The joint venture company will be included in the scope of the consolidated statement.

　　In view of the future market opportunities for the in-depth electrification of various industries and the landing of the dual-carbon target, in order to seize the window period of the intelligent power distribution market and enhance the company’s comprehensive competitiveness, after careful research, the company decided to invest in the establishment of a joint venture company to develop intelligent power distribution related businesses. In the future, the joint venture company will focus on intelligent power distribution business, carry out innovation and optimization around the business model of intelligent power distribution, continue to increase the development of technology and product ecology, improve sales capabilities and delivery capabilities, promote the industrialization of R & D results, promote the rapid development of the company’s intelligent power distribution business, and enhance the company’s comprehensive market competitiveness and brand influence.

　　Jinling Sports: Li Jiangang, director and general manager, plans to increase his holdings by 10 million yuan – 20 million yuan

　　() announcement, director and general manager Li Jiangang intends to increase holdings 10 million yuan – 20 million yuan.

　　Precision Eye launched the "Double Improvement of Quality and Return" action plan

　　() At noon on March 7, the announcement on promoting the "double improvement of quality returns" action plan was disclosed, and it is planned to commit to the high-quality development of the company’s operation and the improvement of the level of sustainable development from five measures, and actively maintain market stability.

　　The company said that it will continue to focus on its main business, adhere to its medical attributes, and build long-term value. On the basis of the company’s successful investment and operation of 28 ophthalmic hospitals and 3 ophthalmic outpatient departments in 21 major cities in China, in the future, the company will continue to implement the development strategy of "national chain + intra-city integration", adhere to both endogenous growth and extension development, not only practice internal skills, strengthen refined management methods, enhance profitability and core competitiveness, but also use the capital markets platform to carry out mergers and acquisitions, further expand the layout in major cities across the country, and consolidate and increase the market share in advantageous regions, while maximizing the diagnosis and treatment needs of patients for eye health.

　　At the same time, the company will pay attention to medical innovation-driven, promote service and product technology upgrades. Improve the company’s internal governance, promote the company’s sustainable development, deeply practice the ESG concept, actively improve the level of ESG governance, and help the company’s high-quality sustainable development.

　　In addition, the company will effectively improve the level of information disclosure, establish a matrixed investor relations channel, and convey the intrinsic value of the company. Investor-oriented, focusing on investor returns, and working with investors to achieve a dynamic balance between performance growth and shareholder returns. Build a "long-term, stable and sustainable" shareholder value return mechanism to ensure that shareholders can effectively enjoy the company’s development results. (Tian Limin)

　　Li Jiangang, general manager of Jinling Sports, plans to increase the company’s shares from 10 million yuan to 20 million yuan

　　Jinling Sports announced that Mr. Li Jiangang, the director and general manager of the company, based on his confidence in the future development of the company and the recognition of long-term investment value, enhances investor confidence, and plans to increase his holdings of the company’s shares within 6 months from the date of disclosure of this announcement. The total amount of the proposed increase is not less than RMB 10 million yuan, not higher than RMB 20 million yuan, and the source of funds required for the increase is equity fund.

　　Jinling Sports: Directors plan to increase their shares by 10 million yuan to 20 million yuan

　　Jinling Sports announced on the evening of March 7 that Li Jiangang, the director and general manager of the company, based on his confidence in the company’s future development and the recognition of long-term investment value, enhanced investor confidence and planned to increase his holdings of the company’s shares. The total amount of the proposed increase is not less than 10 million yuan, not higher than 20 million yuan. The source of funds required for the increase is equity fund. The increase plan does not set a fixed price or price range.

　　Luoping Zinc Power: Fuller Lead-Zinc Mine Suspends Production

　　() Announcement, the company received the "Notice of Suspension of Production" issued by the Luoping County Emergency Management Bureau on March 7, 2024, because the company’s Fuller Lead-Zinc Mine Safety Production License (valid period from March 7, 2021 to March 6, 2024) has expired. According to the "Safety Production Law", "Safety Production License Regulations" and other relevant laws and regulations, all production activities will be stopped from now on, and production can only be resumed after going through the extension formalities and reporting for approval. According to the suspension notice, the company’s Fuller Lead-Zinc Mine will stop all production activities from now on.

　　Jiuan Medical has repurchased 3.08% of the shares at a cost of about 607 million yuan

　　() announced that as of March 7, 2024, the company through the stock repurchase special securities account to the centralized auction transaction accumulated the number of repurchased shares of the company 15.0562 million shares, accounting for 3.08% of the company’s total share capital, the highest transaction price is 41.277 yuan/share, the lowest transaction price is 39.42 yuan/share, the total amount paid is RMB 607 million yuan.

　　Luoping Zinc Power: Fuller Lead-Zinc Mine Suspension, Expected to Have Little Impact on Company Operations

　　Luoping Zinc and Electricity Announcement, the company received the "Notice of Suspension of Production" issued by the Luoping County Emergency Management Bureau on March 7, 2024. The reason is that the valid period of the safety production license of the company’s Fuller Lead-Zinc Mine is from March 7, 2021 to March 6, 2024, which has now expired. According to the "Safety Production Law", "Safety Production License Regulations" and other relevant laws and regulations, all production activities will be stopped from now on, and production can only be resumed after going through the extension procedures and reporting for approval. According to the suspension notice, the company’s Fuller Lead-Zinc Mine will stop all production activities from now on. According to the preliminary estimate of the mine’s production volume in recent years, this suspension has little impact on the company’s operations.

　　() The subsidiary plans to 2113.65 million yuan to participate in the special project of Guangzhou Gongchuangde Storage and invest in Guangzhou Zhiguang Energy Storage

　　Desai Battery announced that Huizhou Desai Battery Co., Ltd. (referred to as "Huizhou Battery"), a wholly-owned subsidiary of the company, signed the "Guangzhou Gongchuang Dereserve Equity Investment Fund Partnership (Limited Partnership) Partnership Agreement" with Guangzhou Gongchuang Dereserve Private Offering Fund Management Co., Ltd. (referred to as "Gongchuang Huiji") on March 7, 2024, and jointly invested in the establishment of Guangzhou Gongchuang Dereserve Equity Investment Fund Partnership (Limited Partnership) (tentative name). The total subscribed capital of the partnership is 2135.00 million yuan, of which Huizhou Battery, as a limited partner, subscribed 2113.65 million yuan in equity fund, with a capital contribution ratio of 99.00%; Gongchuang Huiji, as a general partner, subscribed capital contribution of 213,500 yuan, with a capital contribution ratio of 1.00%.

　　According to the announcement, the partnership will invest in Guangzhou Zhiguang Energy Storage Technology Co., Ltd. for special projects. Guangzhou Zhiguang Energy Storage Technology Co., Ltd. is mainly engaged in the research and application of industrial technology in the field of energy storage. It provides customers with energy storage technology consulting, energy storage system integration, energy storage equipment sales and other businesses in the technical fields of electrochemical energy storage, mechanical (flywheel) energy storage and super capacitor energy storage. It can also provide core key technologies and equipment such as energy storage battery PACK integration, BMS, PCS and EMS for the majority of energy storage system integrators, and can provide battery and battery PACK testing technology services.

　　Desai Battery: The subsidiary plans to invest 2113.65 million yuan to participate in the establishment of an equity investment fund

　　Desai Battery announced on the evening of March 7 that Huizhou Desai Battery Co., Ltd. (referred to as "Huizhou Battery"), a wholly-owned subsidiary of the company, and Guangzhou Gongchuanghuiji Private Offering Fund Management Co., Ltd. signed the "Guangzhou Gongchuangde Reserve Equity Investment Fund Partnership (Limited Partnership) Partnership Agreement" to jointly invest in the establishment of Guangzhou Gongchuangde Reserve Equity Investment Fund Partnership (Limited Partnership) (referred to as "Partnership"). The total subscribed capital of the partnership is 21.35 million yuan. Among them, Huizhou Battery, as a limited partner, subscribed 2113.65 million yuan in equity fund subscription, with a capital contribution ratio of 99.00%. The partnership invests special projects in Guangzhou Zhiguang Energy Storage Technology Co., Ltd.

　　Tang Renshen: February pig sales 272,000 head

　　() Announcement, the company’s February 2024 pig sales 272,000 head (including commercial pigs 247,100 head, piglets 24,900 head), February 2023 pig sales 285,800 head (including commercial pigs 267,800 head, piglets 18,000 head), down 4.83%, down 17.12%; sales revenue totaled 399.82 million yuan, down 9.92%, down 3.44%.

　　Keming Foods: Holding subsidiary Xingjiang Pastoral sold 25,900 pigs in February

　　() Announcement, the holding subsidiary Xingjiang Pastoral sold 25,900 pigs in February, and the sales volume decreased by 39.31% month-on-month, down 52.39% year-on-year; the sales revenue was 27.2403 million yuan, and the sales revenue decreased by 43.71% month-on-month, down 49.47% year-on-year.

　　The controlling shareholder of Jujie Microfiber intends to increase the company’s shares by 15 million to 30 million yuan

　　Jujie Microfiber announced that Suzhou Jujie Investment Co., Ltd., the controlling shareholder of the company, plans to increase its holdings of the company’s shares through the means allowed by the China Securities Regulatory Commission and the Shenzhen Stock Exchange trading system (including but not limited to centralized bidding and block trading, etc.) within the next 6 months from the date of the announcement, with a total proposed increase of not less than 15 million yuan and not more than 30 million yuan.

　　The general manager of Jinling Sports plans to increase the company’s shares by 10 million to 20 million yuan

　　Jinling Sports announced that Li Jiangang, the director and general manager of the company, plans to increase his holdings of the company’s shares within 6 months from the date of disclosure of the announcement, and the total amount of the proposed increase is not less than 10 million yuan and not more than 20 million yuan.

　　Keming Foods: Xingjiang Pastoral’s pig sales in February fell by 52.39% year-on-year.

　　Keming Food announced that the company’s holding subsidiary Xingjiang Pastoral sold 25,900 live pigs in February 2024, and the sales volume decreased by 39.31% month-on-month, a year-on-year decrease of 52.39%; the sales revenue was 27.2403 million yuan, and the sales revenue decreased by 43.71% month-on-month, a year-on-year decrease of 49.47%.

　　From January to February, the company sold 68,500 pigs, down 20.94% from the same period last year; the cumulative sales revenue was 75.6314 million yuan, down 23.86% from the same period last year.

　　Zuoli Pharmaceutical: The exclusive variety Lingze tablets are listed as the national second-level protected variety of traditional Chinese medicine

　　() Announcement, the company received the "Certificate of Traditional Chinese Medicine Protected Variety" issued by the State Drug Administration, and the company’s exclusive variety Lingze Tablets was listed as the national second-level protected variety of traditional Chinese medicine.

　　Tang Renshen: In February 2024, the sales revenue of live pigs was about 400 million yuan, a decrease of 3.44% compared with the previous month.

　　Tang Renshen announced on the evening of March 7 that the company’s pig sales in February 2024 were 272,000, down 4.83% year-on-year and 17.12% month-on-month; the total sales revenue was about 400 million yuan, down 9.92% year-on-year and 3.44% month-on-month. The cumulative pig sales in January-February 2024 were 600,200, up 15.85% year-on-year; the sales revenue was about 814 million yuan, up 1.07% year-on-year.

　　Jujie Microfiber: The controlling shareholder Jujie Investment plans to increase the company’s shares by 15 million yuan – 30 million yuan

　　On the evening of March 7, Jujie Microfiber announced that the board of directors of the company recently received the "notice letter on the plan to increase the company’s shares" issued by the controlling shareholder Suzhou Jujie Investment Co., Ltd. (hereinafter referred to as "Jujie Investment"). The company’s controlling shareholder Jujie Investment plans to increase the company’s shares within the next 6 months from the date of this announcement through the means allowed by the China Securities Regulatory Commission and the Shenzhen Stock Exchange trading system (including but not limited to centralized bidding and block trading, etc.), with a total amount of not less than RMB 5 million yuan and not more than RMB 0 yuan.

　　Allianz sharp vision: March 7 to buy back the company’s shares 10,000 shares

　　On the evening of March 7, () announced that on March 7, 2024, the company repurchased 10,000 shares of the company for the first time through centralized bidding transactions, accounting for 0.01% of the company’s total share capital.

　　Garden Bio: The company’s share repurchase has been completed

　　On the evening of March 7, Garden Bio announced that on September 14, 2023, the company repurchased the company’s shares through a centralized auction transaction through a special securities account for share repurchase. As of March 6, 2024, the company had repurchased 9,307,200 shares through a centralized auction transaction through a special securities account for share repurchase, accounting for 1.69% of the company’s current total share capital. The company’s share repurchase has been completed.

　　Civil Explosion Optoelectronics: 289,533 shares of the company were repurchased on March 6

　　On the evening of March 7, () announced that on March 6, 2024, the company repurchased 289,533 shares of the company for the first time through the stock trading system of the Shenzhen Stock Exchange in a centralized bidding mode, accounting for 0.2766% of the company’s total share capital.

　　Rijiu Optoelectronics: Accumulated repurchase of 3,506,800 shares of the company

　　On the evening of March 7, () announced that from February 8 to March 6, 2024, the company repurchased a total of 3,506,800 shares of the company through a centralized auction transaction through a repurchase special securities account, accounting for about 1.25% of the company’s current total share capital.

　　Rambler: Buyback of company shares 320,000 on March 7

　　On the evening of March 7, Rambler announced that on March 7, 2024, the company repurchased 320,000 shares of the company in a centralized bidding mode for the first time through the special securities account for share repurchase, accounting for 0.0360% of the company’s total share capital.

　　Huamao shares: repurchased 3 million shares of the company on March 7

　　On the evening of March 7, () announced that on March 7, 2024, the company repurchased 3,000,000 shares of the company through a centralized auction transaction through a special securities account for share repurchase, accounting for 0.32% of the company’s current total share capital.

　　Tofulong: Professional technology serves biomedicine and helps the development of human health

　　On March 7, () released an announcement on the "Double Improvement of Quality Return" action plan. The company said that after 30 years of development, it has grown into a comprehensive pharmaceutical equipment service provider that provides pharmaceutical processes, core equipment, and system engineering overall solutions for global pharmaceutical companies. With its competitive advantages in the industry such as technological innovation, perfect sales network layout, leading brand influence, and comprehensive solution services, the company is in a leading position in the field of domestic pharmaceutical equipment, and continues to narrow the gap with international leaders. While exploring overseas markets, it gradually realizes domestic substitution.

　　Yingke Medical: Give full play to the company’s comprehensive competitive advantages and develop into a global industry leader

　　On March 7, () issued an announcement on the "Double Improvement of Quality Return" action plan. The company said that it has accumulated more than 10 years of R & D and production experience, and has fully integrated hardware, software, infrastructure and the company’s proprietary technology and expertise. As of June 30, 2023, the company has completed 8 self-developed and self-produced projects, and new products cover 9 product categories and more than 60 product series.

　　Xingqi Eye Medicine: Will continue to increase investment in research and development to improve the product layout in various fields of ophthalmology

　　On March 7, () issued an announcement on the "Double Improvement of Quality and Return" action plan. The company said that since its establishment, it has always attached importance to the research and development of new products, and will develop new products with independent intellectual property rights as the company’s goal of continuous progress and innovation. R & D investment has increased year by year. In the past three years, the company’s R & D investment has been 84 million yuan, 118 million yuan, and 190 million yuan, accounting for 12.13%, 11.47%, and 15.22% of operating income respectively. After years of development, the company’s R & D center has seven process technology platforms such as conventional ophthalmic preparations, ophthalmic gels, and sustained-release preparations, as well as evaluation technology platforms such as quality research, pharmacological pharmacogenesis research and drug packaging material research.

　　Shouhang Hi-Tech: Signed a 429 million yuan solar thermal + photovoltaic integrated project equipment service supply contract

　　Recently, the company and China Energy Construction Group Northwest Power Construction Engineering Co., Ltd. signed the "Tangshan Haitai New Energy Technology joint stock company solar thermal + photovoltaic integrated project tower concentrating heat collection system procurement contract", the contract stipulates that the seller is the buyer Tangshan Haitai New Energy Technology joint stock company solar thermal + photovoltaic integrated project to provide contract equipment and services. The total contract amount is RMB 429 million yuan.

　　Keming food: holding subsidiary Xingjiang pastoral pig sales revenue in February 2724.03 million yuan, down 43.71%

　　Keming Food announced on the evening of March 7 that the holding subsidiary Xingjiang Pastoral sold 25,900 pigs in February 2024, and the sales volume decreased by 39.31% month-on-month and 52.39% year-on-year; the sales revenue was 2724.03 million yuan, and the sales revenue decreased by 43.71% month-on-month and 49.47% year-on-year. From January to February 2024, the company sold 68,500 pigs cumulatively, down 20.94% from the same period last year; the cumulative sales revenue was 75.6314 million yuan, down 23.86% from the same period last year.

　　Jilin Aodong issued 2 billion yuan medium-term notes accepted for registration

　　() Announcement, the company recently received the "Notice of Acceptance of Registration" issued by the China Interbank Market Dealers Association (China Market Association Note [2024] MTN208), the Dealers Association decided to accept the company’s medium-term note registration, the company’s medium-term note The registration amount is 2 billion yuan, and the registration amount is valid within 2 years from the date of signing the notice.

　　Shouhang Hi-Tech: Signed a 430 million yuan solar thermal + photovoltaic integrated project tower concentrating heat collection system procurement contract

　　Shouhang Hi-Tech announced that the company and China Energy Construction Group Northwest Power Construction Engineering Co., Ltd. signed the "Tangshan Haitai New Energy Technology joint stock company solar thermal + photovoltaic integrated project tower concentrating system procurement contract", the company for Tangshan Haitai New Energy Technology joint stock company solar thermal + photovoltaic integrated project (tower concentrating system) to provide contract equipment and services, the total contract amount 430 million yuan.

　　Shouhang Hi-Tech: Signed a 429 million yuan solar thermal + photovoltaic integrated project tower concentrating heat collection system procurement contract

　　Shouhang Hi-Tech announced that recently, the company (hereinafter referred to as the "seller") and China Energy Construction Group Northwest Electric Power Construction Engineering Co., Ltd. (referred to as the "buyer") signed the "Tangshan Haitai New Energy Technology joint stock company solar thermal + photovoltaic integrated project tower concentrating heat collection system procurement contract", the contract stipulates that the seller is the buyer Tangshan Haitai New Energy Technology joint stock company solar thermal + photovoltaic integrated project (tower concentrating heat collection system) to provide contract equipment and services. The total contract amount (tax included) is RMB 429 million yuan.

　　Luoxin Pharmaceutical and Shenzhen Unknown Jun have reached a strategic cooperation on the commercialization of intestinal microbiota transplantation (FMT)

　　() Announcement: On March 7, 2024, the company and Shenzhen Unknown Jun Biotechnology Co., Ltd. (hereinafter referred to as "Shenzhen Unknown Jun") signed a "Strategic Cooperation Framework Agreement" in Shenzhen, Shenzhen Unknown Jun and/or its affiliates will transplant their intestinal flora into medical technology authorized companies and/or their affiliates to carry out exclusive commercialization cooperation within the scope of cooperation areas and channels agreed upon by both parties, including but not limited to distribution, sales, promotion, etc.

　　The specific content of cooperative medical technology is the intestinal flora transplantation project ("FMT"), which involves wrapping fecal bacteria lyophilized powder or fecal bacteria particles in capsules and entering the human intestine by oral administration; or transplanting fecal bacteria isolated from the feces of healthy people into the intestine by nasal feeding, gastric tube insertion, and digestive endoscopic spraying, so as to restore the dynamic balance of intestinal flora, so as to achieve the purpose of treating various intestinal diseases caused by intestinal flora imbalance.

　　The announcement said that the company has long focused on the digestive field. This time, the company signed a "Strategic Cooperation Framework Agreement" with Shenzhen Unknown Jun to reach a strategic cooperation on the commercialization of intestinal microbiota transplantation ("FMT"), which will help the company further improve its strategic layout in the digestive field and enhance its comprehensive competitiveness.

　　Zuoli Pharmaceutical: Lingze Tablets received the certificate of protected varieties of traditional Chinese medicine

　　Zuoli Pharmaceutical announced that the company has received the "Certificate of Traditional Chinese Medicine Protected Variety" issued by the State Drug Administration. The company’s exclusive variety Lingze Tablets is listed as the national second-level protected variety of traditional Chinese medicine, and the protection period is from March 1, 2024 to March 1, 2031.

　　Shennong Technology’s application is withdrawn and the application documents are added by summary procedure

　　() Announcement, on March 7, 2024, the company issued shares to specific objects by summary procedure in 2023, and the sponsor submitted to the Shenzhen Stock Exchange an application for withdrawing the application documents of Hainan Shennong Technology joint stock company to issue shares to specific objects by summary procedure.

　　The company’s current production and operation are normal, and it will also actively promote the purchase and sale of rapeseed and other businesses to promote the large-scale development of the company’s rapeseed seed business. The withdrawal of the application documents for issuing shares to specific objects through the simplified procedure will not have a significant impact on the company’s normal production and operation and sustainable and stable development, and will not harm the interests of the company and shareholders, especially minority shareholders.

　　Capital Airlines Hi-Tech signed a major contract related to 429 million yuan

　　Shouhang Hi-Tech announced that recently, the company (the "seller") and China Energy Construction Group Northwest Electric Power Construction Engineering Co., Ltd. (the "buyer") signed the "Tangshan Haitai New Energy Technology joint stock company solar thermal + photovoltaic integrated project tower concentrating heat collection system procurement contract", the contract stipulates that the seller is the buyer Tangshan Haitai New Energy Technology joint stock company solar thermal + photovoltaic integrated project (tower concentrating heat collection system) to provide contract equipment and services, the total contract amount (tax included) 429 million yuan, accounting for about 65.73% of the company’s 2022 annual operating income.

　　The shareholders’ meeting will be held on March 25 to consider proposals to change the company’s registered capital, amend the company’s articles of association, and handle the registration of industrial and commercial changes

　　Canaan Smart announced that the first extraordinary general meeting of shareholders will be held on March 25, 2024, and online voting will be held on the same day. The equity registration date is March 20, and investors who hold Canaan Smart shares after the market closes on that day can participate in the voting.

　　Venue: Ningbo Canaan intelligent electric joint stock company conference room, 315 Kaiyuan Road, Cixi City, Zhejiang Province.

　　The shareholders’ meeting audited a total of one proposal, as follows:

　　1. "Proposal on Changing the Registered Capital of a Company and Amending and Handling the Registration of Industrial and Commercial Changes".

　　Guangdong Construction Engineering subsidiary jointly won the bidding for Guangzhou to develop Tianjin Xiqing District 750MW wind power project

　　() Announcement, Guangdong Yuantian Engineering Co., Ltd. (referred to as "Yuantian Company"), a wholly-owned subsidiary of the company, received the "Notice of winning the bidding" from Guangzhou Trading Group Co., Ltd.

　　The "win the bidding notice" determines that the consortium formed by Yuantian Company (member party) and China Energy Construction Group Guangdong Thermal Power Engineering Co., Ltd. (organizer) is the win the bidding unit of " () Tianjin Xiqing District 750MW Wind Power Project EPC General Contracting [JG2024-0695]". The contract content is the code packet of the released version specified in the invite tenders document. The winning bid price of the project is 4.893 billion yuan, and the total construction period of the project is 18 months. Among them, the construction task undertaken by Yuantian Company is about 1.846 billion yuan.

　　According to the invite tenders document, the project plans to install 120 single-unit capacity 6.25MW wind turbines, with an installed capacity of 750MW, and two new 220kV boosting stations. According to the joint tender agreement of the consortium, Yuantian Company is responsible for the civil engineering of 750MW wind turbines (including hoisting platforms, fan foundations), all road engineering construction within the scope of the project, the renovation of Lishuang Highway, all project temporary land use and related compensation for the project, environmental protection engineering, soil and water conservation engineering, labor safety and industrial hygiene engineering, safety monitoring engineering and other related procedures; China Energy Construction Group Guangdong Thermal Power Engineering Co., Ltd. is responsible for the survey and design, all fan units, tower cylinders, box transformers, high and low voltage cables, all equipment and materials procurement of 220KV booster stations, 750MW fan unit hoisting, all 35KV collector lines construction and safety engineering (including tower materials, wires, fittings and other materials procurement), 220KV booster station construction and safety engineering, 220KV outgoing line and opposite side interval renovation engineering materials procurement, construction and safety construction. Special project report preparation, special project acceptance, equipment supervision.

　　Guangdong Construction Engineering: Subsidiaries jointly won the bidding of Guangzhou Development Tianjin Xiqing District 750MW wind power project EPC general contracting project

　　Guangdong Construction Engineering announced on the evening of March 7 that the consortium formed by Guangdong Yuantian Engineering Co., Ltd. (referred to as "Yuantian Company") (member party) and China Energy Construction Group Guangdong Thermal Power Engineering Co., Ltd. (organizer) is the winning unit of the EPC general contract [JG2024-0695] for the "Guangzhou Development Tianjin Xiqing District 750MW Wind Power Project". The winning bid price is about 4.893 billion yuan, and the total construction period of the project is 18 months. Among them, the construction task undertaken by Yuantian Company is about 1.846 billion yuan. According to the invite tenders document, the project plans to install 120 single-machine capacity 6.25MW wind turbines, with an installed capacity of 750MW, and build 2 new 220kV booster stations.

　　ST has a tree: plans to transfer 17% stake in CCCC New Energy to Lu Yicheng

　　ST Youkeshu announced that in order to comprehensively focus on the main business of cross-border e-commerce, optimize the investment structure, and further improve the profitability of assets, Youkeshu Technology joint stock company (referred to as "Youkeshu" or "Company") plans to transfer the 17% equity (registered capital contribution 34 million yuan) of Jiangsu CCCC New Energy Technology Co., Ltd. (referred to as "CCCC New Energy") held by its wholly-owned subsidiary Nanjing Keshu Technology Co., Ltd. (referred to as "Nanjing Keshu") to Lu Yicheng at a price of 40 million yuan. After the completion of this transfer, Nanjing Keshu will no longer hold the equity of CCCC New Energy.

　　China-UK Technology 48.405 million Restricted Shares Available for Circulation on March 13

　　() Announcement, the number of shares issued before the company’s initial public offering is 48.405 million shares, accounting for 64.37% of the company’s total share capital, and the date of listing and circulation is March 13, 2024.

　　Fan Zhihong and Chen Haibing, directors of Jinbei Electric, have reduced their holdings by a total of 3.29 million shares

　　() announcement, the company’s director and vice president Fan Zhihong, Chen Haibing reduction plan period has expired, a total reduction of the company’s shares 3.29 million shares.

　　Huapengfei: The company signed a strategic cooperation framework agreement with the joint stock company of Ririshun Supply Chain Technology

　　() Announcement, the company signed a strategic cooperation framework agreement with the Ririshun Supply Chain Technology joint stock company.

　　Huakai Yibai granted 16.722 million restricted shares at a grant price of 9.82 yuan/share

　　() announcement, the company 2024 restricted stock incentive plan provisions of the restricted stock grant conditions have been achieved, the company deliberated and passed the "on the grant of restricted stock to the incentive object", agreed and determined that the incentive plan restricted stock grant date is March 7, 2024, to meet the conditions of 114 incentive objects granted 16.722 million shares of restricted stock, the grant price is 9.82 yuan/share.

　　Huapengfei: Signed a strategic cooperation framework agreement with Ririshun Supply Chain

　　Huapengfei announced on the evening of March 7 that the company and Ririshun Supply Chain Technology joint stock company (referred to as "Ririshun Supply Chain") have their own resources and advantages in the field of supply chain, and are committed to commercial cooperation in cross-border integrated logistics. After friendly negotiation between the two sides, it was decided to establish a strategic partnership and sign the "Strategic Cooperation Framework Agreement".

　　Fu Xin Ping An Bank Director Qualifications Approved

　　Ping An Bank issued an announcement, recently, Ping An Bank joint stock company received the "State Financial Supervision and Administration Administration on Ping An Bank Fu Xin qualification", the State Financial Supervision and Administration approved Fu Xin Ping An Bank joint stock company director qualifications.

　　Luoxin Pharmaceutical and micro-ecological R & D enterprise Unknown Jun reached a strategic cooperation

　　On March 7, Luoxin Pharmaceutical announced that the joint stock company of Luoxin Pharmaceutical Group (hereinafter referred to as "the company") and Shenzhen Unknown Jun Biotechnology Co., Ltd. (hereinafter referred to as "Shenzhen Unknown Jun") signed the "Strategic Cooperation Framework Agreement" in Shenzhen, Shenzhen Unknown Jun will hold the intestinal flora transplantation (FMT) medical technology authorized company to carry out exclusive commercialization cooperation within the agreed cooperation area and channel scope, and the two sides will establish a win-win strategic partnership on the basis of complementary advantages, mutual benefit and common development.

　　The application prospect of microbiota transplantation is huge, and the industry is leading

　　The intestinal microbiota is called the "hidden organ" of the human body. More and more studies have found that the intestinal microbiota has an important connection with the occurrence of human health and diseases. When the intestinal microbiota is unbalanced, it will lead to the occurrence of many diseases. There are as many as 85 indications related to the treatment of intestinal microbiota. By regulating the intestinal microbiota, it can affect the health of the human body. The intestinal microbiota can not only become drugs but also serve as new drug targets, so the intestinal microbiota has great application prospects in the treatment of certain diseases. At present, the intestinal microbiota transplantation (FMT) has gradually become one of the most cutting-edge and hot research fields in the industry. Intestinal microbiota transplantation is to transplant the functional flora in the intestines of healthy people into patients to rebuild a healthy intestinal microbiome, in order to restore the diversity of intestinal flora, improve the balance of intestinal flora, and achieve the treatment of intestinal and parenteral diseases.

　　Shenzhen Unknown Junzheng, which has reached a cooperation with Luoxin Pharmaceutical this time, is currently the industry-leading AI + BT microbiome research and product development platform, and a leader in the domestic micro-ecology field. According to its official website, Unknown Junzheng has built a leading micro-ecological strain sample and data asset library, and created an international leading bioinformation analysis platform composed of four core platforms of AI drug discovery, algorithms, clinical analysis, and data/computing. It is worth mentioning that Unknown Jun also has an industry-leading micro-ecological pipeline matrix, many of which are First-in-class, and have completed the layout in the fields of cancer, nervous system, digestive system, immune system and other diseases, covering all mainstream drug forms such as formula bacteria, genetically engineered microorganisms, bacterial metabolites, and enterobacteria transplantation. The pipeline layout and promotion capabilities are world-leading. He is the first (only) FMT/enterobacteria transplantation management system in Asia that meets FDA requirements. The production process strictly follows GMP specifications; the production environment is cleaner than the industry standard; the raw and auxiliary materials used are all pharmaceutical grade to ensure the safety of the product.

　　The barriers in the digestion field are profound, and the commercialization experience and advantages of established pharmaceutical companies are obvious

　　As an established enterprise that has been deeply involved in the pharmaceutical industry for more than 30 years, Luoxin Pharmaceutical has long focused on unmet clinical needs in core disease fields such as digestion, respiration, and anti-tumor. It has listed more than 10 dosage forms, more than 150 varieties, and more than 300 product specifications, forming a rich and competitive product portfolio. The core products are in a leading position in the market for digestive and respiratory diseases. According to IQVIA2023 data, the company’s digestive products, omeprazole enteric-coated capsules, rabeprazole sodium for injection, and lansoprazole for injection, have ranked first in the market share. It is worth noting that the company’s Class 1 innovative drug Tegorasan Tablets is the first self-developed potassium ion competitive acid blocker (P-CAB) in our country. It has been identified as a major special project of national "major new drug creation" science and technology. Currently, two indications have been approved for marketing: reflux esophagitis and duodenal ulcer. The third indication "combined with appropriate antibacterial therapy to eradicate Helicobacter pylori" has been accepted by the State Drug Administration. Recently, the results of the Phase III clinical study of pukanapeptide tablets for the treatment of functional constipation have reached the main efficacy endpoint. In addition, Tegorasan injection is also under development, and there is no similar injection product on the market worldwide. In the field of digestion, whether it is the esophagus of the upper digestive tract, the stomach or the intestines, gallbladder and pancreas of the lower digestive tract, it is the key direction of the company’s future expansion, and is committed to becoming an active leader in the ecosystem of China’s digestive field. Luoxin Pharmaceutical has built a professional commercialization team since the second half of 2021, and has the management experience of localizing the sales system of multinational pharmaceutical companies and the commercialization experience of innovative drugs. It has realized the core product of digestive system, Tegola raw tablets, in the early stage of listing, which has enabled thousands of doctors to quickly gain drug experience accumulation. It was approved to be included in the national medical insurance catalogue at a reasonable price in the same year. The following year of listing,

　　Commercialization Blue Ocean Domestic policy support Cooperation Complementary advantages of both parties Deeply empowered

　　Since the launch of the Human Microbiome Project in the United States in 2007, the development of micro-ecological medicine and microbial-related technologies has entered an accelerated stage. A large number of microbial pharmaceutical star companies have emerged. According to incomplete statistics, there are more than 50 micro-ecological pharmaceutical companies in the world, and multinational pharmaceutical giants such as Pfizer, Roche, Johnson & Johnson have also laid out micro-ecological pharmaceutical tracks. Intestinal microbiota transplantation research has grown rapidly since 2013 and has received more attention in recent years. There are more than 500 clinical trials related to intestinal microbiota transplantation registered internationally, involving indications including: pseudomembranous enteritis (Clostridium difficile infection), ulcerative colitis, Crohn’s disease, chronic functional diarrhea and constipation, diabetes, insomnia, obesity, autism, liver cirrhosis, allergic diseases, antibiotic resistance, anti-tumor drug resistance, depression, Parkinson’s disease and many other diseases. The patient base is huge. According to public information on the domestic government website, "Microbiota transplantation is becoming a new track in the field of biomedicine, and the global size of the market segment is about 50 billion US dollars." The domestic micro-ecological pharmaceutical industry is in a stage of rapid start, and the future market space is extremely broad. Intestinal microbiota transplantation is expected to become the next explosive point of the pharmaceutical industry. In 2023, the "National Medical Service Technical Specification (2023 Edition) " announced by the National Health Commission officially included "intestinal microbiota transplantation" in the technical specification, supporting the rapid development of the industry.

　　Luoxin Pharmaceutical’s digestive field, whether it is the professionalism of the sales team or the department resources at the hospital end, has experienced the polishing and accumulation of time, and the commercialization ability is more advantageous. Unknown Jun is at the leading level in the field of intestinal flora transplantation (FMT) in terms of sample database, R & D capabilities and production process. This cooperation is Luoxin Pharmaceutical’s always-keen insight and forward-looking layout of market demand. The revolutionary significance and clinical value of intestinal flora transplantation as a diagnosis and treatment method will be realized through Luoxin Pharmaceutical’s commercialization capabilities covering hospitals at all levels across the country and Unknown Jun’s self-developed precision enterobacteria transplantation solutions, and jointly explore the domestic blue ocean market opportunities.

　　Note: Unknown Jun CMC production workshop

　　(): The company and its wholly-owned subsidiaries signed the "Cooperation Framework Agreement" with Gree Supply Chain and Gechuang Supply Chain

　　Keheng share announcement, the company and its wholly-owned subsidiaries Yingde Keheng, Zhuhai Keheng, Zhuhai Haoneng, Haoneng Technology and Gree Supply Chain, Gechuang Supply Chain signed the "Cooperation Framework Agreement". Gree Supply Chain and Gechuang Supply Chain gave Jiangmen Keheng, Yingde Keheng, Zhuhai Keheng, Zhuhai Haoneng and Haoneng Technology a total of RMB 650 million for the procurement of raw materials.

　　Tang Renshen: February pig sales revenue of about 400 million yuan

　　Tang Renshen announced that the company’s pig sales in February 2024 272,000, down 4.83% year-on-year and 17.12% month-on-month; sales revenue totaled 399.82 million yuan, down 9.92% year-on-year and 3.44% month-on-month. From January to February 2024, the cumulative pig sales volume was 60,200, up 15.85% year-on-year; sales revenue was 81.39 million yuan, up 1.07% year-on-year.

　　Diou Home Furnishing Shareholder Sichuan Development Fund reduced its holdings by 41,100 shares

　　() Announcement that as of the expiration date of the reduction plan, the shareholder Sichuan Development Fund has reduced the company’s shares 41,100 shares through centralized bidding mode, accounting for 0.01% of the company’s total share capital. As of the disclosure date of this announcement, the shareholder Sichuan Development Fund’s reduction plan has been implemented.

　　Pulo Pharmaceutical announced the 2023 annual rights distribution plan, proposing to pay 3.16 yuan for 10 grants

　　() issued an announcement on March 8, the company’s 2023 annual equity distribution plan is as follows: based on the total share capital 1.1693236 billion shares, cash dividends of 3.16 yuan will be distributed to all shareholders for every 10 shares, and a total of 370 million yuan will be distributed.

　　According to the 2023 annual performance report of Prologis Pharmaceutical, the company’s operating income 11.474 billion yuan, an increase of 8.81% year-on-year; net profit attributable to shareholders of listed companies 1.055 billion yuan, an increase of 6.69% year-on-year; basic earnings per share of 0.90 yuan, the same period last year was 0.84 yuan.

　　The main business of Pullo Pharmaceutical joint stock company covers the R & D, production and sales of API intermediates, innovative drug R & D and production services (CDMO), preparations, etc., as well as import and export trade business. API intermediate business includes cephalosporin series, penicillin series, psychiatric series, cardiovascular and cerebrovascular series and veterinary drug API intermediate series; innovative drug R & D and production services (CDMO) include R & D services, commercial human drug projects, commercial veterinary drug projects and other commercializations; preparation business includes anti-infective, cardiovascular and cerebrovascular, psychiatric and anti-tumor categories. The company is a large comprehensive pharmaceutical enterprise integrating research, development and production of APIs, preparations and pharmaceutical intermediates. It is a national key high-tech enterprise and a key enterprise in the pharmaceutical industry of Zhejiang Province. It has been awarded the title of "Top Ten Enterprises" in the pharmaceutical industry of Zhejiang Province for nine consecutive years, and the title of AAA credit rating enterprise of Bank of China in Zhejiang Province for ten consecutive years. It has been ranked among the largest taxpayers in Zhejiang Province for five consecutive years. The trademark of "Kangyu" is a famous trademark in Zhejiang Province.

　　(Source of data: iFinD)

　　Keheng shares will hold a shareholders’ meeting on March 25 to consider the proposal to sign a cooperation framework agreement and related party transactions

　　Keheng shares announced that the second extraordinary general meeting of shareholders will be held on March 25, 2024, and the online voting will be held on the same day. The equity registration date is March 18, and investors who hold Keheng shares after the market closes on that day can participate in the voting.

　　Venue: Jiangmen City Jianghai District Jiaotou Jiaoxing South Road No. 22 Jiangmen City Keheng Industrial joint stock company 3 floor conference room.

　　The shareholders’ meeting audited a total of one proposal, as follows:

　　1. Proposal on Signing and Related Transactions.

　　Jinling Sports: General Manager Li Jiangang plans to increase his stake in the company from 10 million yuan to 20 million yuan

　　On the evening of March 7, Jinling Sports announced that the company received the "Notice Letter of Share Increase Plan" issued by Mr. Li Jiangang, director and general manager of the company on March 7, 2024. Mr. Li Jiangang, director and general manager of the company, plans to increase his holdings of the company’s shares within 6 months from the date of disclosure of this announcement. The total amount of the proposed increase is not less than 10 million yuan and not more than 20 million yuan. The source of funds required for the increase is equity fund.

　　Pangang Group: 22 Pangang 01 will pay interest on March 11

　　On March 7, Pangang Group Co., Ltd. issued an interest payment announcement that it will pay interest for the period from March 10, 2023 to March 9, 2024 on March 11, 2024.

　　According to the interest payment plan, the coupon rate of the current bond variety 1 "22 Pangang 01" is 3.59%. This interest payment is RMB 35.90 (tax included) per lot (face value 1,000 yuan) of "22 Pangang 01". After tax deduction, the actual per-lot interest paid by individuals and securities investment fund bondholders is 28.72 yuan; the actual per-lot interest paid by non-resident enterprises (including QFII and RQFII) is 35.90 yuan.

　　Yitong Century: Re-identified as a high-tech enterprise

　　On the evening of March 7, () announced that recently, the company received the "High-tech Enterprise Certificate" jointly issued by the Guangdong Provincial Department of Science and Technology, the Guangdong Provincial Department of Finance, and the Guangdong Provincial Taxation Bureau of the State Administration of Taxation. This is a re-identification of the company’s original high-tech enterprise certificate after the valid period expires.

　　Longquan Shares: The implementation of this share repurchase plan has been completed

　　On the evening of March 7, () announced that the company implemented the share repurchase for the first time on February 28, 2024 through the repurchase special securities account in the form of centralized bidding transactions. As of March 6, 2024, the company has repurchased a total of 3290,000 shares of the company through the share repurchase special account in the form of centralized bidding transactions, accounting for 0.58% of the company’s total share capital. So far, the company’s share repurchase plan has been implemented.

　　Jiuan Medical: Accumulated repurchase of 15056236 shares

　　On the evening of March 7, Jiuan Medical announced that on February 8, 2024, the company repurchased the company’s shares in a centralized bidding mode for the first time through the special securities account for share repurchase. As of March 7, 2024, the company repurchased a total of 15056,236 shares of the company’s shares in a centralized bidding transaction through the special securities account for share repurchase, accounting for 3.08% of the company’s total share capital.

　　Jinling Sports: General Manager plans to increase holdings 10 million yuan – 20 million yuan

　　On March 7, Jinling Sports announced that Li Jiangang, the general manager of the company, plans to increase the company’s shares, and the total amount of the proposed increase is not less than 10 million yuan, not higher than 20 million yuan.

　　Copyright Daily Economic News

　　Luoxin Pharmaceutical: Signed a strategic cooperation framework agreement with Shenzhen Unknown Jun

　　On March 7, Luoxin Pharmaceutical announced that the company signed the "Strategic Cooperation Framework Agreement" with Shenzhen Unknown Jun. Shenzhen Unknown Jun and/or its affiliates will transfer their intestinal flora transplantation medical technology authorized companies and/or their affiliates to carry out exclusive commercialization cooperation within the scope of cooperation areas and channels agreed upon by both parties, including but not limited to distribution, sales, promotion, etc.

　　Luoxin Pharmaceutical joins hands with Shenzhen Unknown Jun to further enrich the layout of the digestive tract

　　On March 7, Luoxin Pharmaceutical announced that the company and Shenzhen Unknown Jun Biotechnology Co., Ltd. (hereinafter referred to as "Shenzhen Unknown Jun") signed a "Strategic Cooperation Framework Agreement" in Shenzhen, Shenzhen Unknown Jun will hold the intestinal flora transplantation (FMT) medical technology authorized company to carry out exclusive commercialization cooperation within the agreed cooperation area and channel scope between the two parties, and the two parties will establish a win-win strategic partnership on the basis of complementary advantages, mutual benefit and common development.

　　Broad application prospects of microbiota transplantation

　　It is understood that the intestinal microbiota is known as the "hidden organ" of the human body, which is the normal microorganism of the human intestine. By regulating the intestinal microecology, it can affect the health of the human body. The intestinal microbiota can not only become a drug but also serve as a new drug target. Therefore, the intestinal microbiota has great application prospects in the treatment of certain diseases. At present, intestinal microbiota transplantation (FMT) has gradually become one of the most cutting-edge and popular research fields in the industry. Intestinal microbiota transplantation is to transplant the functional microbiota in the intestines of healthy people into patients to rebuild a healthy intestinal microbiota, so as to restore the diversity of intestinal microbiota, improve the balance of intestinal microbiota, and achieve the treatment of intestinal and extraintestinal diseases.

　　Shenzhen Unknown Junzheng, which has reached a cooperation with Luoxin Pharmaceutical this time, is currently the industry-leading AI + BT microbiome research and product development platform, and a leader in the domestic micro-ecology field. According to its official website, Shenzhen Unknown Junzheng has built a leading micro-ecological strain sample and data asset library, and created an international leading bioinformation analysis platform composed of four core platforms of AI drug discovery, algorithms, clinical analysis, and data/computing. It is worth mentioning that Shenzhen Unknown also has an industry-leading micro-ecological pipeline matrix, many of which are first-in-class, and have completed the layout in the fields of cancer, nervous system, digestive system, immune system and other diseases, covering all mainstream drug forms such as formula bacteria, genetically engineered microorganisms, bacterial metabolites, and enterobacteria transplantation. The pipeline layout and promotion capabilities are world-leading, and it is the first (only) FMT/enterobacteria transplantation management system in Asia that meets FDA requirements.

　　The barriers in the field of digestive system are profound, and the commercialization experience and advantages of established pharmaceutical companies are obvious

　　As an established enterprise that has been deeply involved in the pharmaceutical industry for more than 30 years, Luoxin Pharmaceutical has long focused on the unmet clinical needs in the core disease fields such as digestion, respiration, and anti-tumor. It has listed more than 10 dosage forms, more than 150 varieties, and more than 300 product specifications, forming a rich and competitive product portfolio. The core products are in the leading position in the digestive system and respiratory system disease drug market. According to IQVIA2023 data, the company’s digestive system products, such as omeprazole enteric-coated capsules, rabeprazole sodium for injection, and lansoprazole for injection, rank first in the market share.

　　Luoxin Pharmaceutical has been building a professional commercialization team since the second half of 2021, and has the management experience of localizing the sales system of multinational pharmaceutical companies and the commercialization experience of innovative drugs. It has realized that the core product of digestive system, Tegola raw tablets, has enabled thousands of doctors to quickly gain drug experience in the early stage of listing, and was included in the national medical insurance catalog at a reasonable price in the year it was approved. The following year, it was listed, and the new commercialization speed of hospital access reached 1,000 and sales doubled.

　　Commercialization Blue Ocean Domestic policy support Cooperation Complementary advantages of both parties Deeply empowered

　　It is understood that since the launch of the Human Microbiome Project in the United States in 2007, the development of micro-ecological medicine and microbial-related technologies has entered an accelerated stage, and a large number of microbial pharmaceutical star companies have emerged. According to incomplete statistics, there are more than 50 global micro-ecological pharmaceutical companies, and multinational pharmaceutical giants such as Pfizer, Roche, Johnson & Johnson have also laid out micro-ecological pharmaceutical tracks. Intestinal microbiota transplantation research has grown rapidly since 2013, and has received more attention in recent years. There are more than 500 clinical trials related to enterobacteria transplantation registered internationally, involving indications including: pseudomembranous enteritis (Clostridium difficile infection), ulcerative colitis and many other diseases, with a large patient base. The public information on the domestic government website shows that "flora transplantation is becoming a new track in the field of biomedicine, and the global scale of the market segment is about 50 billion US dollars." The domestic micro-ecological pharmaceutical industry is in the stage of rapid start, and the future market space is extremely broad. Intestinal flora transplantation is expected to become the next flash point of the pharmaceutical industry. In 2023, the "National Medical Service Technical Specification (2023 Edition) " announced by the National Health Commission officially included "intestinal flora transplantation" in the technical specification to support the rapid development of the industry.

　　At present, Luoxin Pharmaceutical’s digestive system field, whether it is the professionalism of the sales team or the department resources at the hospital end, has experienced the polishing and accumulation of time, and the commercialization ability is more advantageous. Shenzhen Unknown Jun is at the leading level in the field of intestinal flora transplantation (FMT) in terms of sample database, R & D capabilities and production processes. This cooperation is Luoxin Pharmaceutical’s always-keen insight and forward-looking layout to market demand. The revolutionary significance and clinical value of intestinal flora transplantation as a diagnosis and treatment method will be realized through the commercialization ability of Luoxin Pharmaceutical covering hospitals at all levels across the country and the precision enterobacteria transplantation solution independently developed by Shenzhen Unknown Jun, and jointly explore the domestic blue ocean market opportunities. (Qi Hening)

　　Picture Note: Shenzhen Unknown Jun CMC Production Workshop

　　Dike Co., Ltd.: An advanced packaging and testing equipment has been patented and has not yet been applied to production

　　China Fortune Connect, March 7 – () announced that the company recently obtained a patent certificate issued by the State Intellectual Property Office, the patent name is an advanced packaging and testing equipment. The invention patent is the company’s technology research and development and technical reserves. The patent has not been applied to production and will not have a significant impact on the company’s near-term production and operation, but it will help the company to further improve the intellectual property protection system, give full play to the advantages of independent intellectual property rights, and form a continuous innovation mechanism to maintain the company’s technological leadership and enhance the company’s core competitiveness.

　　Xintian Pharmaceutical: plans to purchase 85.12% equity of Huilun Pharmaceutical by issuing shares

　　() Announcement that the company plans to purchase 85.12% of the shares of Huilun Pharmaceutical held by 88 shareholders of Huilun Pharmaceutical, including Dong Dalun, Dong Zhu and Hainan Qianyao, by issuing shares. After the completion of this transaction, Huilun Pharmaceutical will become a wholly-owned subsidiary of the listed company.

　　Luoxin Pharmaceutical joins hands with Shenzhen Unknown Jun to expand the field of intestinal flora transplantation

　　On the evening of March 7, Luoxin Pharmaceutical announced that it had signed a "Strategic Cooperation Framework Agreement" with Shenzhen Unknown Jun Biotechnology Co., Ltd. (hereinafter referred to as "Shenzhen Unknown Jun"), and Shenzhen Unknown Jun would hold the intestinal flora transplantation (FMT) medical technology authorized company to carry out exclusive commercialization cooperation within the agreed cooperation areas and channels between the two parties.

　　At present, intestinal microbiota transplantation (FMT) has gradually become one of the most cutting-edge and hot research areas in the industry. Intestinal microbiota transplantation is the transplantation of functional microbiota from healthy people’s intestines into patients to rebuild healthy intestinal microbiota, in order to restore intestinal microbiota diversity, improve intestinal microbiota balance, and achieve the treatment of intestinal and extraintestinal diseases.

　　Shenzhen Unknown Junzheng, which has reached a cooperation with Luoxin Pharmaceutical this time, is currently the industry-leading AI + BT microbiome research and product development platform, and a leader in the domestic micro-ecology field. According to its official website, Unknown Junzheng has built a leading micro-ecological strain sample and data asset library, and created an international leading bioinformation analysis platform composed of four core platforms of AI drug discovery, algorithms, clinical analysis, and data/computing. It is worth mentioning that Unknown also has an industry-leading micro-ecological pipeline matrix, many of which are first-in-class, and have completed the layout in the fields of cancer, nervous system, digestive system, immune system and other diseases, covering all mainstream drug forms such as formula bacteria, genetically engineered microorganisms, bacterial metabolites, and intestinal bacteria transplantation. The pipeline layout and propulsion capabilities are world-leading.

　　As an established enterprise that has been deeply involved in the pharmaceutical industry for more than 30 years, Luoxin Pharmaceutical has long focused on unmet clinical needs in core diseases such as digestion, respiration, and anti-tumor. It has listed more than 10 dosage forms, more than 150 varieties, and more than 300 product specifications, forming a rich and competitive product portfolio. The core products are in a leading position in the market for digestive and respiratory diseases. Since the second half of 2021, Luoxin Pharmaceutical has built a professional commercialization team. It has management experience in localization of sales systems of multinational pharmaceutical companies and commercialization experience in the landing of innovative drugs.

　　Intestinal microbiota transplantation research has grown rapidly since 2013, and has received more attention in recent years. More than 500 clinical trials related to intestinal microbiota transplantation have been registered internationally. In 2023, the "National Medical Service Technical Specification (2023 Edition) " announced by the National Health and Health Commission officially included "intestinal microbiota transplantation" in the technical specification, supporting the rapid development of the industry.

　　This cooperation is Luoxin Pharmaceutical has always maintained a keen insight into market demand and a forward-looking layout. The revolutionary significance and clinical value of intestinal flora transplantation as a diagnosis and treatment method are expected to be realized through the commercialization capabilities of Luoxin Pharmaceutical covering hospitals at all levels across the country and the precision enterobacteria transplantation solutions independently developed by Unknown Jun. (Nie Pin)

　　Wall Nuclear Materials: 2 subsidiaries were re-identified as high-tech enterprises

　　On the evening of March 7, () announced that the company’s holding subsidiary, Shanghai Kete New Materials joint stock company and Shanghai Changyuan Electronic Materials Co., Ltd. passed the re-identification of high-tech enterprises and recently received the "High-tech Enterprise Certificate".

　　Luoxin Pharmaceutical and Shenzhen Unknown have reached a strategic cooperation

　　On the evening of March 7, Luoxin Pharmaceutical announced that the joint stock company of Luoxin Pharmaceutical Group (hereinafter referred to as "the company") and Shenzhen Unknown Jun Biotechnology Co., Ltd. (hereinafter referred to as "Shenzhen Unknown Jun") signed the "Strategic Cooperation Framework Agreement" in Shenzhen, Shenzhen Unknown Jun will hold the intestinal flora transplantation (FMT) medical technology authorized company to carry out exclusive commercial cooperation within the agreed cooperation area and channel scope, and the two sides will establish a win-win strategic partnership on the basis of complementary advantages, mutual benefit and common development.

　　Luoxin Pharmaceutical said that the company has been focusing on the digestive field for a long time. This time, the company signed the "Strategic Cooperation Framework Agreement" with Shenzhen Unknown Jun to reach a strategic cooperation on the commercialization of intestinal flora transplantation (FMT), which will help the company to further improve the strategic layout in the digestive field and enhance the company’s comprehensive competitiveness. This agreement is a framework document for the cooperation between the two parties. There are still uncertainties in the follow-up progress, and there are also uncertainties in the impact on the company’s current and future operating results. The signing and performance of this agreement will not affect the independence of the company’s business, and the company’s main business will not become dependent on the partners as a result of

　　It is reported that Shenzhen Unknown Jun is currently the industry-leading AI + BT microbiome research and product development platform, and a leader in the domestic micro-ecology field. According to its official website, Shenzhen Unknown Jun has built a leading microecology strain sample and data asset library, and created an international leading bioinformation analysis platform composed of four core platforms of AI drug discovery, algorithms, clinical analysis, and data/computing.

　　Chenzhan Optoelectronics: Accumulated repurchase of 2064,210 shares

　　On the evening of March 7, () announced that from March 1 to March 7, 2024, the company repurchased 2064,210 shares of the company in a centralized bidding mode through the special securities account for share repurchase, accounting for 1.26% of the company’s total share capital.

　　Jiahe Intelligent: The first repurchase of 140,400 shares

　　On the evening of March 7, () announced that on March 7, 2024, the company repurchased 140,400 shares of the company through a centralized auction transaction through a repurchase special securities account for the first time, accounting for 0.04% of the company’s current total share capital.

　　Luoxin Pharmaceutical and Shenzhen Unknown Jun signed a "Strategic Cooperation Framework Agreement" involving intestinal microbiota transplantation medical technology

　　On the evening of March 7, Luoxin Pharmaceutical announced that on March 7, the company and Shenzhen Unknown Jun Biotechnology Co., Ltd. (hereinafter referred to as "Shenzhen Unknown Jun") signed a "Strategic Cooperation Framework Agreement" in Shenzhen. Shenzhen Unknown Jun and/or its affiliates will transplant their intestinal flora into medical technology authorized companies and/or their affiliates to carry out exclusive commercialization cooperation within the agreed cooperation areas and channels, including but not limited to distribution, sales, promotion, etc. Both parties agreed to establish a win-win strategic partnership on the basis of complementary advantages, mutual benefit and common development.

　　It is understood that the specific connotation of intestinal flora transplantation medical technology is to wrap fecal bacteria lyophilized powder or fecal bacteria particles in capsules and enter the human intestine by oral administration; or transplant fecal bacteria isolated from the feces of healthy people through nasal feeding, gastric tube insertion, and digestive endoscopic spraying into the intestine to restore the dynamic balance of intestinal flora, so as to achieve the purpose of treating various intestinal diseases caused by intestinal flora imbalance.

　　Xintian Pharmaceutical plans to issue an additional 85.12% stake in Huilun Pharmaceutical, forming a dual-category industrial pattern of "traditional Chinese medicine-chemical medicine"

　　Xintian Pharmaceutical announced that the company plans to purchase 85.12% of the equity of Huilun Pharmaceutical held by 88 shareholders of Shanghai Huilun Pharmaceutical joint stock company ("Huilun Pharmaceutical"), including Dong Dalun, Dong Zhu and Hainan Qianyao, by issuing shares. After the completion of this transaction, Huilun Pharmaceutical will become a wholly-owned subsidiary of the company. The price of the shares issued this time is 8.12 yuan/share. This transaction is expected to constitute a major asset restructuring.

　　It is reported that Huilun Pharmaceutical’s main business is the research and development, production and sales of small molecule chemical drugs, and is committed to innovation and development in the fields of immune inflammation, anti-tumor, cardiovascular and cerebrovascular, gynecology, andrology and other diseases. Through this transaction, the company will further extend its industrial layout to cutting-edge pharmaceutical fields such as small molecule chemical drugs, forming a dual-category industrial pattern of "traditional Chinese medicine-chemical drugs", realizing rich integration of product structure, further expansion of therapeutic fields and upgrading of future innovative drug pipelines, and accelerating the establishment of a leading comprehensive pharmaceutical enterprise.

　　Oriental Seiko: No direct partnership with Nvidia

　　() Issued an announcement of abnormal stock trading fluctuations. The company has recently noticed that some media have listed the company as a "robot + Nvidia" concept stock. Many relevant media reports mention Guangdong Jiateng Robot Automation Co., Ltd., a shareholding company of Oriental Seiko. Oriental Seiko takes "intelligent equipment manufacturing" as the strategic core, focuses on the direction of high-end intelligent equipment manufacturing, and its main business layout is in the two fields of "intelligent packaging equipment" and "water power equipment". As of now, Oriental Seiko has no direct cooperative relationship with Nvidia. Based on Oriental Seiko’s shareholding ratio of Jiateng Robotics and the accounting treatment of the investment in Oriental Seiko’s consolidated financial statements, the application of robots or AI-related technologies will not have a significant impact on the company’s operating results in the short term.

　　Xintian Pharmaceutical plans to acquire 85.12% stake in Huilun Pharmaceutical and resume trading on March 8

　　On the evening of March 7, Xintian Pharmaceutical announced that it plans to purchase the 85.12% equity of Huilun Pharmaceutical held by 88 shareholders of Shanghai Huilun Pharmaceutical joint stock company (hereinafter referred to as "Huilun Pharmaceutical"), including Dong Dalun, Dong Zhu and Hainan Qianyao, through the issuance of shares.

　　According to the data, Huilun Pharmaceutical’s main business is the research and development, production and sales of small molecule chemical drugs, and is committed to innovation and development in the fields of immune inflammation, anti-tumor, cardiovascular and cerebrovascular, gynecology, andrology and other diseases. Xintian Pharmaceutical said that after the completion of this transaction, the company will further extend its industrial layout to cutting-edge pharmaceutical fields such as small molecule chemical drugs, forming a dual-category industrial pattern of "traditional Chinese medicine-chemical drugs", realizing rich integration of product structure, further expansion of therapeutic fields and upgrading of future innovative drug pipelines, and relying on the integration with underlying assets to enhance the company’s Product Research & Development capabilities, market competitiveness, sustainable development capabilities and anti-risk capabilities, and accelerate the creation of a leading comprehensive pharmaceutical enterprise.

　　In addition, Xintian Pharmaceutical said that after the company applied to the Shenzhen Stock Exchange, the company’s shares and convertible corporate bonds resumed trading since the market opened on March 8, and convertible corporate bonds resumed conversion on the same day.

　　Huibo Yuntong: Plan to increase funding for big data and AI model research and development projects for enterprise application scenarios

　　() announcement, the proposed increase in funding does not exceed 430 million yuan, for enterprise application scenarios for big data and AI model research and development projects, supplementary working capital.

　　Huilu Ecology was 575,500 shares by Li Junhao, the son of Li Xiaoming, the actual controller

　　() Announcement that Li Junhao, the son of Li Xiaoming, the actual controller of the company, increased his holdings of the company’s shares 575,500 shares on March 6, 2024.

　　Huilu Ecology was 575,500 shares by Li Junhao, the son of Li Xiaoming, the actual controller

　　Huilu Ecological Announcement, Li Junhao, the son of Li Xiaoming, the actual controller of the company, increased his holdings of the company’s shares 575,500 shares on March 6, 2024.

　　Jiansheng Green Energy, a subsidiary of Wenke Holdings, plans to build a photovoltaic power station project

　　() Announcement, the company’s holding subsidiary, Guangdong Jiansheng Green Energy Co., Ltd. (abbreviation: "Jiansheng Green Energy") intends to acquire 100% equity of Huizhou Lingdian New Energy Co., Ltd. (abbreviation: "Project Company"), with the project company as the main body to invest in the construction of rooftop distributed photovoltaic projects, with an estimated total installed capacity of about 7.38MW (subject to the actual installed capacity). The total investment of the project is estimated to be 2625.2 million yuan.

　　This investment in the construction of a photovoltaic power station project is conducive to enhancing the company’s large-scale business advantages. Together with the company’s other independently developed and operated photovoltaic power stations under construction, the company can expand its coverage in the Pearl River Delta region, enhance the company’s overall competitiveness and product service level, and expand the company’s brand influence.

　　Xintian Pharmaceutical’s shares resume trading, convertible bonds resume trading and share conversion

　　Xintian Pharmaceutical announced that the company intends to purchase 85.12% of the equity of Huilun Pharmaceutical held by 88 shareholders of Shanghai Huilun Pharmaceutical joint stock company ("Huilun Pharmaceutical"), including Dong Dalun, Dong Zhu and Hainan Qianyao Enterprise Management Partnership (Limited Partnership), by issuing shares ("this transaction"). Upon application, the company’s shares and convertible corporate bonds will be suspended from the opening of the market on February 23, 2024 to March 7, 2024 (Thursday).

　　During the suspension period, the company signed the "Trading Framework Agreement" with 88 shareholders of Huilun Pharmaceutical, and has formed a preliminary trading intention. Upon application, the company’s shares and convertible corporate bonds will resume trading from the opening of the market on March 8, 2024 (Friday), and convertible corporate bonds will resume conversion on the same day.

　　Huapengfei and Ririshun Supply Chain Signed a Strategic Cooperation Framework Agreement

　　Huapengfei announced that in view of the fact that the company and Ririshun Supply Chain Technology joint stock company have their own resources and advantages in the supply chain field, and are committed to commercial cooperation in cross-border integrated logistics and seek common development, the two parties decided to establish a strategic partnership and sign the "Strategic Cooperation Framework Agreement". On the premise of meeting the service experience and cost competitiveness of Ririshun Supply Chain, the company, as the cross-border logistics service team of Ririshun Supply Chain, is entrusted to undertake the cargo transportation tasks of Ririshun Supply Chain, including but not limited to cross-border trucking services, cross-border maritime transportation services, and cross-border railway transportation services. The company provides customized solutions for Ririshun Supply Chain to assist Ririshun Supply Chain in achieving cost reduction and efficiency increase.

　　Zuoli Pharmaceutical: The company’s exclusive variety Lingze tablets are listed as the national second-level protected variety of traditional Chinese medicine

　　Zuoli Pharmaceutical announced that recently, the company received the "Certificate of Traditional Chinese Medicine Protected Variety" issued by the State Drug Administration. The company’s exclusive variety Lingze Tablet is listed as the national second-level protected variety of traditional Chinese medicine, and the protection period is from March 1, 2024 to March 1, 2031. Lingze Tablet, as one of the important products of the Wuling series, is an exclusive innovative drug for the treatment of benign prostate hyperplasia and the treatment of symptoms such as frequent nocturnal urination. It is a product of the National Basic Drug Catalog and a Class B product of the National Medical Insurance Catalog.

　　The 16.7% shares held by Kunlun Investment, the controlling shareholder of Xiangxue Pharmaceutical, were frozen by the judiciary

　　On the evening of March 7, () issued an announcement saying that recently, the company checked the system of the Shenzhen branch of China Securities Depository and Clearing Co., Ltd., and learned that part of the company’s shares held by the controlling shareholder Guangzhou Kunlun Investment Co., Ltd. (hereinafter referred to as "Kunlun Investment") had been judicially frozen.

　　The announcement shows that the total number of frozen shares held by Kunlun Investment is about 110 million shares, accounting for 73.91% of its shares and 16.7% of the company’s total share capital. As of the announcement date, Kunlun Investment has frozen about 149 million shares, accounting for 100% of its shares and 22.59% of its total share capital.

　　Dongfang Seiko: The company does not control Jiateng robots and does not participate in the operation and management of Jiateng robots

　　Dongfang Seiko announced that the company has recently noticed that some media have listed the company as a "robot + Nvidia" concept stock. Many relevant media reports mention Guangdong Jiateng Robot Automation Co., Ltd. (hereinafter referred to as "Jiateng Robot"), a shareholding company of Dongfang Seiko. The company explains the relevant matters as follows:

　　(1) Explanation of Dongfang Seiko’s investment in Jiateng Robot. In June 2014, Dongfang Seiko disclosed the "Announcement on Cash Subscription for 20% Equity of Guangdong Jiateng Robot Automation Co., Ltd." The company invested in Jiateng Robot in cash subscription to obtain 20% of its capital contribution, and the transaction consideration was 49.12 million yuan. Since June 2014, Dongfang Seiko has never made additional investment in Jiateng Robot. During this period, due to the introduction of new shareholders and the increase in registered capital of Jiateng Robot, as of now, Dongfang Seiko’s investment in Jiateng Robot is 19.8366%.

　　(2) Dongfang Seiko’s explanation for not controlling Jiateng Robot and not participating in the operation and management of Jiateng Robot. According to the Company Law and enterprise accounting standards, Dongfang Seiko, as a minority shareholder, does not have the control of Jiateng Robot. Since the initial investment in Jiateng Robot, Dongfang Seiko has never included Jiateng Robot in the scope of consolidated statements, nor has it substantially participated in the operation and management of Jiateng Robot.

　　(3) The impact of investing in Jiateng Robotics on the financial performance of Dongfang Seiko. Since the initial investment in Jiateng Robotics in June 2014, in the regular reports disclosed every year, Dongfang Seiko has strictly adhered to the relevant provisions of the enterprise accounting standards, recognized Jiateng Robotics as an "associate" for long-term equity investment, and recognized ROI in each reporting period using the equity method. Jiateng Robotics has not paid dividends from 2020 to 2023.

　　(4) Explanation that Dongfang Seiko and Nvidia do not have a direct cooperative relationship. Dongfang Seiko takes "intelligent equipment manufacturing" as the strategic core, focuses on the direction of high-end intelligent equipment manufacturing, and is mainly engaged in the two fields of "intelligent packaging equipment" and "aquatic power equipment". As of now, Dongfang Seiko has no direct cooperative relationship with Nvidia. Based on Dongfang Seiko’s shareholding ratio for Jiateng Robotics and the accounting treatment of the investment in Dongfang Seiko’s consolidated financial statements, the application of robots or AI-related technologies will not have a significant impact on the company’s operating results in the short term.

　　Shouhang Hi-Tech signed a procurement contract for the tower concentrating heat collection system of the solar thermal + photovoltaic integrated project

　　Shouhang Hi-Tech announced that recently, the company (the "seller") and China Energy Construction Group Northwest Electric Power Construction Engineering Co., Ltd. (the "buyer") signed the "Tangshan Haitai New Energy Technology joint stock company solar thermal + photovoltaic integrated project tower concentrating heat collection system procurement contract", the contract stipulates that the seller is the buyer Tangshan Haitai New Energy Technology joint stock company solar thermal + photovoltaic integrated project (tower concentrating heat collection system) to provide contract equipment and services, the total contract amount (tax included) 428,718,280.00 yuan.

　　Liberal Arts Co., Ltd.: Holding subsidiary plans to invest in the construction of photovoltaic power station projects

　　Wenke shares announced on the evening of March 7 that the holding subsidiary Guangdong Jiansheng Green Energy Co., Ltd. plans to acquire 100% equity of Huizhou Lingdian New Energy Co., Ltd., and invest in the construction of rooftop distributed photovoltaic projects with the project company as the main body. The total installed capacity is expected to be about 7.38MW. The total investment of the project is estimated to be 2625.2 million yuan.

　　Huibo Yuntong: It is planned to raise no more than 432 million yuan for big data and AI model research and development projects for enterprise application scenarios

　　Huibo Yuntong announced on the evening of March 7 that it intends to issue shares to specific objects, and the total amount of proceeds raised does not exceed 432 million yuan, which is used for big data and AI large model research and development projects for enterprise application scenarios and supplementary working capital.

　　Shengxun shares: 244,400 shares were repurchased for the first time

　　On the evening of March 7, () announced that on March 7, 2024, the company repurchased 244,400 shares of the company through a centralized bidding transaction through a special securities account for share repurchase, accounting for 0.30% of the company’s current total share capital.

　　Xintian Pharmaceutical plans to acquire 85.12% stake in Huilun Pharmaceutical and resume trading on the 8th

　　Xintian Pharmaceutical announced that the company plans to purchase 85.12% of the equity of Huilun Pharmaceutical held by 88 Huilun Pharmaceutical shareholders including Dong Dalun, Dong Zhu and Hainan Qianyao by issuing shares. After the completion of this transaction, Huilun Pharmaceutical will become a wholly-owned subsidiary of the company. As of now, the audit and evaluation of the underlying assets of this transaction have not been completed, and the transaction price of the underlying assets of this transaction has not yet been determined. This transaction is expected to constitute a major asset restructuring. Huilun Pharmaceutical’s main business is the research and development, production and sales of small molecule chemical drugs, and is committed to innovative development in the fields of immuno-inflammation, anti-tumor, cardiovascular and cerebrovascular, gynecological, andrology and other diseases. The company said that after the completion of this transaction, the company will further extend its industrial layout to frontier pharmaceutical fields such as small molecule chemical drugs, forming a dual-category industrial pattern of "traditional Chinese medicine-chemical drugs", and realize the rich integration of product structure, further expansion of the therapeutic field and the upgrade of future innovative drug pipelines. The company’s shares and convertible corporate bonds will resume trading from the opening of the market on March 8, 2024, and convertible corporate bonds will resume conversion on the same day.

　　Huarong Chemical appointed Zhang Wei as the general manager of the company

　　() Announcement: On March 7, 2024, the board of directors of the company deliberated and approved the "Proposal on the Appointment and Removal of Senior Managers of the Company". Tang Chong was removed as the general manager and continued to serve in the company. Zhang Wei was appointed as the general manager, and at the same time, Zhang Wei’s deputy general manager, CFO, and board secretary were removed. Cai Xiaoqin was appointed as the CFO and Li Si was appointed as the secretary of the board of directors.

　　Teyi Pharmaceutical announced the annual rights distribution plan for 2023, and plans to pay 5 yuan for 10 to 4 shares

　　() announced on March 8 that the company’s 2023 annual equity distribution plan is as follows: based on the total share capital 364.7389 million shares, a cash dividend of RMB 5.00 will be distributed to all shareholders for every 10 shares, a total of RMB 182 million will be distributed, and a capital provident fund will be transferred to all shareholders for every 10 shares.

　　According to Special Pharmaceutical’s annual performance report for 2023, the company’s operating income was 1.067 billion yuan, an increase of 20.38% year-on-year; net profit attributable to shareholders of listed companies was 253 million yuan, an increase of 42.07% year-on-year; basic earnings per share were 0.77 yuan, 0.57 yuan in the same period last year.

　　Teyi Pharmaceutical Group joint stock company is mainly engaged in the research and development, production and sales of proprietary Chinese medicines, chemical preparations and chemical raw materials. The company’s main products include cough treasure tablets, Ganmaoling granules, compound Houttuynia cordata tablets, pharyngitis tablets, Xuesaitong dispersible tablets, Ginkgo biloba dispersible tablets, Yixinshu granules, aluminum magnesium carbonate chewable tablets, Maple Polygonum Changweikang tablets, omeprazole enteric-coated capsules, roxithromycin capsules, etorubicin tablets, levofloxacin hydrochloride tablets, skin disease blood poison pills, Yikang Beisong cream, children’s cough syrup, children’s Kechuanling granules, Jinkui kidney gas tablets, etc. In addition, 27 medicines including Cough Treasure Tablets, Jinkui Shenqi Tablets, Erythromycin Enteric-coated Tablets and Erythromycin Tablets have been recognized as "Guangdong Province High-tech Products" by the Guangdong Provincial Department of Science and Technology. The company’s special brand has been recognized as "Guangdong Province Famous Trademark" by the Guangdong Provincial Administration for Industry and Commerce, and the special brand has also been rated as "Guangdong Province Leading Brand in the Industry of Proprietary Chinese Medicine and Traditional Chinese Medicine Decoction Pieces" by the Guangdong Provincial Pharmaceutical Industry Association.

　　(Source: Flush iFinD)

　　Pengdu agriculture and animal husbandry controlling shareholders acting in concert were judicially frozen 646 million shares

　　() Announcement, the company recently received a notice from the company’s controlling shareholder, Shanghai Pengxin (Group) Co., Ltd. (referred to as "Pengxin Group"), the concerted action person of Lhasa Economic and Technological Development Zone Houkang Industrial Co., Ltd. (referred to as "Houkang Industrial"), that its holdings of 646 million shares of the company (10.13% of the company’s total share capital) were frozen by the judiciary.

　　Luoxin Pharmaceutical and Shenzhen Unknown signed a strategic cooperation framework agreement

　　Luoxin Pharmaceutical announced that the company and Shenzhen Unknown Jun Biotechnology Co., Ltd. signed the "Strategic Cooperation Framework Agreement" on March 7, 2024. Shenzhen Unknown Jun and/or its affiliates will transplant their intestinal flora into medical technology authorized companies and/or their affiliates to exclusively carry out commercialization cooperation within the scope of cooperation areas and channels agreed upon by both parties, including but not limited to distribution, sales, promotion, etc. Both parties agreed to establish a win-win strategic partnership on the basis of complementary advantages, mutual benefit and common development.

　　Nenghui Technology terminates the implementation of the 2021 restricted stock incentive plan

　　() Announcement, the board of directors and the board of supervisors of the company deliberated and approved the "Proposal on Terminating the Implementation of the 2021 Restricted Stock Incentive Plan and Repurchase, Cancellation and Voiding of Restricted Shares", and intends to decide to terminate the implementation of the incentive plan, and to repurchase and cancel all the first-class restricted stocks that have been granted but not yet lifted and all the second-class restricted stocks that have been granted but not yet vested, and the relevant supporting documents shall be terminated together.

　　Lianke Technology announced the 2023 annual rights distribution plan, proposing to pay 5 yuan out of 10

　　() announced on March 8 that the company’s 2023 annual equity distribution plan is as follows: Based on the total share capital 202.356 million shares, cash dividends of RMB 5.00 will be distributed to all shareholders for every 10 shares, and a total cash dividend of RMB 101 million will be distributed. No bonus shares will be sent, and no capital reserve will be converted into equity.

　　According to the 2023 annual performance report released by Lianke Technology, the company’s operating income was 1.917 billion yuan, an increase of 4.45% year-on-year; net profit attributable to shareholders of listed companies was 169 million yuan, an increase of 51.27% year-on-year; basic earnings per share were 0.88 yuan, 0.61 yuan in the same period last year.

　　Shandong Lianke Technology joint stock company is a high-tech enterprise specializing in the research and development, production and sales of silica and carbon black. The silica products mainly include LK, LKHD and LKSIL series rubber industrial silica and non-rubber industrial silica; carbon black products mainly include N100, N200, N300, N400, N500, N600, N700 series and LK series rubber carbon black and special carbon black. The company’s silica and carbon black products have been certified by Pirelli Tire, Yokohama, Zhengxin Rubber, Cooper Tire, () and (), (), Aeolus Tire, Shuangxing Tire, Pulin Chengshan and other well-known tire and footwear companies in the world-renowned tire companies.

　　(Source: Flush iFinD)

　　Huarong Chemical announced the 2023 annual rights and interests distribution plan, proposing to send 2 yuan to 10

　　Huarong Chemical announced on March 8 that the company’s 2023 annual equity distribution plan is as follows: Based on the total share capital 480 million shares, cash dividends of RMB 2.00 will be distributed to all shareholders for every 10 shares, and a total of RMB 96 million will be distributed. No bonus shares will be sent, and no capital reserve will be converted into equity.

　　According to Huarong Chemical’s annual performance report for 2023, the company’s operating income was 1.059 billion yuan, down 6.67% year-on-year; net profit attributable to shareholders of listed companies was 139 million yuan, an increase of 13.53% year-on-year; basic earnings per share were 0.29 yuan, 0.27 yuan in the same period last year.

　　Huarong Chemical joint stock company is an advanced enterprise dedicated to the green recycling and comprehensive utilization of potassium hydroxide. The main products are high-quality potassium hydroxide. The company focuses on the development of electronic-grade, photovoltaic-grade, reagent-grade, food-grade fine potassium products and chlorine products around modern industries such as new fertilizers, high-end daily chemicals, food and medicine, new energy, and electronic information. The company has won the titles and awards of "National Advanced Collective of Petroleum and Chemical Industry", "Third Class of Science and Technology Progress Award", "Sichuan Province Oil and Gas Chemical Industry" Twelfth Five-Year "Development Advanced Unit", "Sichuan Famous Brand Product Title", "Sichuan Province Famous Trademark" and other titles and awards.

　　(Source: Flush iFinD)

　　Jujie Microfiber: The controlling shareholder plans to increase the company’s shares by 1,500 to 30 million yuan

　　China Fortune Connect, March 7 – Jujie Microfiber announced that based on confidence in the company’s future development and recognition of long-term investment value, the company’s controlling shareholder Suzhou Jujie Investment Co., Ltd. plans to increase its holdings of the company’s shares within the next 6 months from the date of this announcement through the means allowed by the China Securities Supervision Commission and the Shenzhen Stock Exchange trading system (including but not limited to centralized bidding and block trading, etc.), with a total proposed increase of not less than 15 million yuan and not more than 30 million yuan.

　　Xintian Pharmaceutical plans to purchase part of the equity of Huilun Pharmaceutical and resume trading on March 8

　　Xintian Pharmaceutical announced on the evening of March 7 that it plans to purchase 85.12% of the equity of Huilun Pharmaceutical held by 88 Huilun Pharmaceutical shareholders including Dong Dalun, Dong Zhu and Hainan Qianyao by issuing shares. After the completion of this transaction, Huilun Pharmaceutical will become a wholly-owned subsidiary of the listed company. This transaction does not involve raising supporting funds. At the same time, Xintian Pharmaceutical’s shares and convertible corporate bonds have resumed trading since the opening of the market on March 8, and convertible corporate bonds have resumed conversion on the same day.

　　Focus on small molecule chemicals

　　Before this transaction, Xintian Pharmaceutical’s main business was the research and development, production and sales of proprietary Chinese medicines. The product indications were mainly for gynecological and urinary diseases, and covered oral, mammary and thyroid, anti-cold, heat-clearing, blood supplementation, cardiovascular diseases, anti-tumor and other disease fields.

　　In the field of traditional Chinese medicine, Xintian Pharmaceutical has 32 drug production batches, including 10 national medical insurance catalog varieties, 1 national essential drug catalog variety, 12 over-the-counter (OTC) varieties, and 12 exclusive varieties. The main product pipeline market such as gynecology and urinary system, and many main varieties have achieved a sales scale of over 100 million single products. Among them, Xintian Pharmaceutical has a leading clinical market position and industry position in the gynecological field.

　　After years of traditional Chinese medicine industry marketing network construction and market mining, the current product market has covered more than 30 provinces, autonomous regions and municipalities across the country, prescription drug products cover more than 12,000 hospitals above the county (district) level; OTC products cover more than 800 drug chain companies, nearly 100,000 stores, and established long-term and stable business relationships with the headquarters of nearly 500 domestic drug chain companies.

　　The main business of the target company, Huilun Pharmaceutical, is the research and development, production and sales of small molecule chemical drugs, and is committed to innovation and development in the fields of immuno-inflammation, anti-tumor, cardiovascular and cerebrovascular, gynecological, andrology and other diseases. After years of technical accumulation and business development, Huilun Pharmaceutical has approved a number of chemical drugs for listing. As of the signing date of the plan, Huilun Pharmaceutical has approved 12 varieties for listing, including 1 new improved drug and 3 first imitation drugs. The drug treatment fields cover immuno-inflammation, anti-tumor, gynecology, andrology, cardiovascular and cerebrovascular systems, etc.

　　Huilun Pharmaceutical’s exclusive product, Silvestrat Sodium for Injection, is mainly used to improve acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) accompanied by systemic inflammatory response syndrome. The product has obtained the qualification of accelerated review by the State Food and Drug Administration, and has obtained clinical approval through emergency review. It is also the first drug approved in China for the treatment of ALI and ARDS.

　　In terms of performance, from 2022 to 2023, Huilun Pharmaceutical achieved revenue of 414 million yuan and 998 million yuan, and net profit was – 264 million yuan and 30.8325 million yuan.

　　Constitutes a material asset reorganization

　　According to the transaction plan, Xintian Pharmaceutical plans to purchase 85.12% of the equity of Huilun Pharmaceutical held by 88 Huilun Pharmaceutical shareholders including Dong Dalun, Dong Zhu and Hainan Qianyao by issuing shares. This transaction does not involve raising supporting funds. As of the signing date of the plan, Xintian Pharmaceutical has held 14.88% of the equity of Huilun Pharmaceutical; after the completion of this transaction, Huilun Pharmaceutical will become a wholly-owned subsidiary of the listed company.

　　The price of the shares issued this time is 8.12 yuan/share. As of the signing date of the plan, the audit and evaluation of the underlying assets of this transaction have not been completed, and the transaction price has not yet been determined. Judging from the unaudited financial data of the target company in 2023, this transaction is expected to constitute a major asset restructuring, but it will not lead to a change in the actual controller of the company.

　　In addition, Dong Dalun, Dong Zhu, Hainan Qianyao, LIUZHENWANG, Huilun Yuyi, Huilun Feihe, Huilun Yunbai, Tianxiang Shengtai, Wang Jinhua, Wang Guangping, Wang Wenyi, Chen Yurong, Ji Weijia, Dong Dahua, Dong Daheng, and Yuan Ye are related parties of Xintian Pharmaceutical, and this transaction constitutes a related party transaction.

　　Xintian Pharmaceutical said that after the completion of this transaction, the listed company will further enrich the product pipeline in the company’s specialty field, improve the product matrix, and provide patients with more comprehensive medication options, thereby improving the market coverage and influence of the listed company in the main drug field. At the same time, Xintian Pharmaceutical will integrate the marketing activities of both parties, deeply integrate in the fields of gynecology, andrology and other diseases, improve the efficiency of drug marketing activities in the same department, enrich the choice space of doctors, and simultaneously increase the layout of sales channels such as OTC and e-commerce, as well as sales coverage areas and coordinated development.

　　At the same time, Xintian Pharmaceutical will further extend its industrial layout to cutting-edge pharmaceutical fields such as small molecule chemical drugs, forming a dual-category industrial pattern of "traditional Chinese medicine – chemical drugs", realizing rich integration of product structure, further expansion of treatment field and upgrading of future innovative drug pipelines, superimposing the synergy effect of clinical medical research and marketing activities with the products of the target company, further enhancing the clinical marketing capabilities of the company’s core products and the market competitiveness of product pipelines, accelerating the creation of a leading comprehensive pharmaceutical enterprise, and enhancing Xintian Pharmaceutical’s competitiveness in the pharmaceutical industry.

　　Zhongbing Hongjian: Completion acceptance of some investment projects with proceeds raised

　　() Announcement, the company’s wholly-owned subsidiary Shandong North Binhai Machinery Co., Ltd. (referred to as North Binhai) has completed all the construction content of the approval, and the acceptance team composed of relevant departments and experts has completed the on-site completion acceptance. The environmental protection, fire protection, safety facilities, occupational health, construction and safety engineering quality and project files of the project have passed the special project acceptance organized by the local competent department or construction unit according to the regulations and requirements in the early stage. Recently, the project received the approval of the relevant departments through the completion acceptance.

　　Copyright Daily Economic News

　　Three special ropeway: the company received a first instance court verdict involving 72.9764 million yuan

　　() Announcement, recently, the company received the "Civil court verdict" of the People’s Court of Wuhan East Lake New Technology Development Zone, Hubei Province ([2023] Hubei 0192 Minchu No. 3153). The subject matter of the lawsuit is 72.9764 million yuan. The first-instance judgment result: The defendant, Wuhan Sante Cableway Group Joint Stock Company, within 60 days from the effective date of the judgment, registered the change of the land use right under the WP National Use (2000) No. 150 and WP National Use (2000) No. 151 "State-owned Land Use Certificate" to the name of the third party, Wuhan Hanjintang Investment Co., Ltd.; rejected the other claims of the plaintiff, Hubei Heyuesheng Investment Co., Ltd.

　　Zuoli Pharmaceutical: Lingze Tablets Received the "Certificate of Protected Varieties of Traditional Chinese Medicine"

　　On March 7, Zuoli Pharmaceutical announced that Lingze tablets received the "Certificate of Protected Varieties of Traditional Chinese Medicine".

　　Copyright Daily Economic News

　　Continue to increase shareholder returns, Jianfan Bio promotes the implementation of the "Double Improvement of Quality Returns" action plan

　　() An announcement on promoting the implementation of the "Double Improvement of Quality and Return" action plan was issued after the market close on March 7. In terms of operation, the company focuses on the main business of blood purification, increases investment in research and development, launches series of blood purification products, and builds a world-class high-tech medical technology enterprise group. In terms of returning shareholders, it actively distributes dividends and shares development results with shareholders, and enhances investor confidence through repurchase, increase holdings, etc.

　　Data show that since its listing in 2016, the company has implemented a cash dividend plan for seven consecutive years, with a cumulative cash dividend of 2.642 billion yuan, which is 6.35 times the company’s net IPO raising of 416 million yuan and 1.87 times the company’s net financing (IPO and refinancing) since its listing. The proportion of the company’s cash dividends to net profit has increased from 41% in 2016 to 60% in 2022. The company also shares the company’s development results with investors through various forms of dividends such as "transfer of equity" and "share repurchase". In the future, the company will, in accordance with the relevant provisions of the Articles of Association and the Shareholder Dividend Return Plan for the Next Three Years (2023-2025), take into account the Strategy and Development Plan and Shareholder Return, and continue to increase the return to shareholders under the premise of ensuring the company’s business expansion, so as to create greater value for shareholders.

　　In the secondary market, the company carried out share increase and repurchase to actively maintain market stability and enhance investor confidence. Dong Fan, the controlling shareholder and actual controller, chairperson and general manager of the company, increased his holdings by a total of 200 million yuan through centralized bidding transactions from January 20, 2022 to March 11, 2022. The company implemented two phases of the share repurchase plan of the company. The first phase of the share repurchase plan completed on November 12, 2021 had a total transaction amount of 500 million yuan, and the number of shares repurchased 8.8478 million shares, accounting for 1.10% of the company’s total share capital at that time. On July 17, 2023, the company launched the share repurchase plan of the company for the second time, using equity funds to repurchase the company’s shares in a centralized bidding mode of not less than 250 million yuan and not more than 500 million yuan. As of February 28, 2024, the company has repurchased 17.5827 million shares, accounting for 2.18% of the company’s total share capital, and the repurchase amount is 342 million yuan, which will continue to be implemented. So far, the company’s two-phase share repurchase plan has repurchased the company’s shares for a total of 842 million yuan, and the cumulative number of repurchased shares 2643.05 million, accounting for 3.27% of the company’s total share capital. The company has actively launched the share repurchase plan to effectively maintain market stability and boost investor confidence.

　　Feneng Oriental: It plans to apply for a comprehensive exposure credit line of not more than 2.43 billion yuan to the Financial Institution Group within the next year

　　China Fortune Connect, March 7 – () announcement said that according to the needs of production and operation, in order to reduce financing costs and improve the efficiency of capital use, the company (including wholly-owned and holding subsidiaries) plans to apply to banks, financial leasing companies and other Financial Institution Groups within the next year for a total amount of not more than RMB2.43 million in comprehensive exposure credit lines and handle corresponding loans, financial leasing, factoring and other businesses.

　　Rifeng shares: In order to ensure the smooth construction and implementation of related projects, it plans to apply for a project loan from the bank with its own assets as collateral

　　China Fortune Connect, March 7 – Rifeng announced that in order to ensure the smooth construction and implementation of the company’s "new energy and special equipment cable assembly project", the company plans to mortgage the state-owned construction land and its under-construction projects in Longchang Community, West District, Zhongshan City, Guangdong Province to the Zhongshan Branch of the Bank of Communications joint stock company, and add no more than 150 million yuan (exposure 150 million yuan) of bank credit and apply for project loans. The specific loan amount and term are subject to the final agreement signed with the bank. The company’s application for project loans from the bank with its own assets as collateral is to meet the capital needs of the company’s under-construction projects, which is conducive to the long-term sustainable development of the company.

　　Funeng Oriental: plans to cancel its subsidiary Zhongshan Daewoo, which will help the company improve the efficiency of asset operation

　　China Fortune Connect, March 7 – Funeng Oriental announced that the company intends to cancel its wholly-owned subsidiary Zhongshan Daewoo Intelligent Equipment Co., Ltd. This cancellation is conducive to the company’s further integration of resources, improvement of asset operation efficiency, and reduction of management costs. After the cancellation is completed, Zhongshan Daewoo will no longer be included in the company’s consolidated financial statements, which will not have a material impact on the company’s consolidated financial statements, nor will it have an adverse impact on the company’s overall business development and profitability.

　　Double in 10 days! Big bull stocks urgently clarify

　　On the evening of March 7, Dongfang Seiko, a bull stock with 8 daily trading limits in 10 days, issued an announcement of abnormal fluctuations in stock trading for the third time.

　　This time, the company disclosed in detail the investment in Jiateng Robotics, whose current shareholding ratio is close to 20%. The company said that the application of robots or AI-related technologies will not have a significant impact on the company’s operating results in the short term, while continuing to emphasize that "there is no direct partnership with Nvidia".

　　From the perspective of the transaction returns after the daily limit on March 7, the game of hot money in Dongfang Seiko is in full swing. There are many well-known hot money seats in the top five of buying and selling, and the net transaction is relatively close.

　　Holding Jiateng Robot 19.84%

　　On March 7, Dongfang Seiko rose by the daily limit again. In this way, the company’s closing price rose by a cumulative 20% for 3 consecutive trading days. According to the relevant regulations of the Shenzhen Stock Exchange, this situation belongs to the abnormal fluctuation of stock trading. Since February 23, the company has harvested 8 daily limit in 10 days, and the cumulative increase in stock price has reached 100%.

　　On the evening of March 7, the company released its third announcement of abnormal stock price fluctuations since the current round of gains.

　　The announcement said that the company has recently noticed that some media have listed the company as a "robot + NVIDIA" concept stock, and many relevant media reports have mentioned Guangdong Jiateng Robot Automation Co., Ltd. (referred to as "Jiateng Robot").

　　The announcement shows that in June 2014, Dongfang Seiko invested in Jiateng Robot in cash subscription to obtain 20% of its investment ratio, and the transaction consideration was 49.12 million yuan. Since June 2014, Dongfang Seiko has never made additional investment in Jiateng Robot. During this period, due to the introduction of new shareholders and the increase in registered capital of Jiateng Robot, as of now, Dongfang Seiko’s investment ratio in Jiateng Robot is 19.8366%.

　　The company said that since the initial investment in Jiateng Robot, Dongfang Seiko has never included Jiateng Robot in the scope of consolidated statements, nor has it substantially participated in the operation and management of Jiateng Robot. The company adopts the equity method to confirm the ROI of the investment in each reporting period, and the confirmed ROI in the past three years is 3.06 million yuan, 3.88 million yuan, 3.14 million yuan and – 1.78 million yuan respectively.

　　The announcement said that as of now, Dongfang Seiko has no direct cooperation relationship with Nvidia. Based on Dongfang Seiko’s shareholding ratio for Jiateng Robot and the accounting treatment of the investment in Dongfang Seiko’s consolidated financial statements, the application of robots or AI-related technologies will not have a significant impact on the company’s operating results in the short term.

　　Jiateng robot repeatedly sends "good"

　　Although Dongfang Seiko has tried its best to downplay the influence of Jiateng Robotics and Nvidia, it has repeatedly released "good news" on official Weibo and other channels, and has been noticed by the market.

　　According to its official website, Jiateng Robotics is a global enterprise headquartered in Shunde, China. It was established in 2002 and focuses on the research and development and manufacturing of mobile robot (AGV) bodies. It is the world’s leading provider of AGV robots and intelligent logistics warehousing systems. "Committed to promoting the transformation and upgrading of the manufacturing industry and the development of new quality productivity, to be the best AGV to help people around the world carry and run errands."

　　On January 9, Jiateng Robot released a message on the official Weibo, based on years of long-term cooperation and deep consensus in the intelligent application field, NVIDIA, the global artificial intelligence leader, highly recognized Jiateng’s leading generative AI, and presented the application in a multi-scene and multi-modal display at the CES exhibition in the United States where intelligent innovation projects are gathered. In particular, the successful application of Jiateng’s generative AI on laser forklifts has depicted a vivid and magnificent vision for the promotion and popularization of thinking mobile robots in the industry, and has become a typical example of NVIDIA’s global artificial intelligence players at CES.

　　On February 28, Jiateng Robot’s official Weibo account was again favorable, claiming that its Jiateng 8.5 cm ultra-thin fork arm omnidirectional unmanned stacking forklift conference was held in the studio of Guangdong Jiateng Robot Headquarters.

　　From the dragon and tiger list on March 7, the short-term game of capital in Oriental Seiko does not seem to have ended. There are still many well-known hot money seats in the top five of buying and selling, including CITIC Securities Xi’an Suzaku Street Sales Department, East Asia Qianhai Securities Shenzhen Branch, etc. In addition, Shenzhen Stock Connect seats also participated.

　　BYD applies for a patent for a hydraulic control system to prevent the load from shaking

　　According to the announcement of the State Intellectual Property Office, the joint stock company applied for a project entitled "Hydraulic control system and its control method, and vehicle", public number CN117658019A, and the application date is August 2022.

　　The patent abstract shows that the present invention provides a hydraulic control system and a control method thereof, as well as a vehicle. The hydraulic control system includes an oil pump, a first oil cylinder connected to the oil pump, and a motor for driving the oil pump to supply oil to the first oil cylinder. The telescopic rod of the first oil cylinder is connected to the first load member. The hydraulic control system also includes a controller connected to the motor and a buffer switch connected to the controller. The controller is used to control the motor. The buffer switch is used to drive the first load member in the telescopic rod of the first oil cylinder. When moving in the extended direction to a preset stroke, a buffer signal is generated and sent to the controller; the controller controls the motor to reduce from the first speed to the second speed based on the buffer signal, so that the speed at which the telescopic rod of the first oil cylinder drives the first load member to move is reduced from the In the present invention, the controller controls the motor speed to decrease or even stop slowly based on the buffer signal, which can eliminate the impact caused by inertia when the first cylinder mechanically travels to the end, and prevent the first load member from shaking.

　　BYD applies for patents related to sodium-ion batteries to provide over-discharge protection

　　According to the announcement of the State Intellectual Property Office, BYD’s joint stock company applied for a project entitled "A sodium-ion battery positive electrode piece, sodium-ion battery and application", public number CN117673243A, and the application date is August 2022.

　　The patent abstract shows that this application provides a sodium-ion battery positive electrode sheet, a sodium-ion battery, and applications. The sodium-ion battery positive electrode sheet includes an active material and an over-discharge protector, including an over-discharge protector of the chemical formula M.

　　BYD applies for patents for anti-skid devices and rail vehicles to reduce wear on running wheels

　　According to the announcement of the State Intellectual Property Office, the BYD joint stock company applied for a project called "anti-skid device and rail vehicle", public number CN117657223A, and the application date is August 2022.

　　The patent abstract shows that the present application discloses an anti-skid device and a rail vehicle. The rail vehicle is used to travel on a metal rail beam, and the anti-skid device includes a skid monitoring unit and an electromagnetic coil; the skid monitoring unit is used to monitor the skid of the rail vehicle; the electromagnetic coil is arranged facing the metal rail beam and is electrically connected to the skid monitoring unit. When the skid monitoring unit detects the skid of the rail vehicle, the voltage or current of the electromagnetic coil is increased, so that the magnetic force of the electromagnetic coil on the metal rail beam is increased. Therefore, during the running of the rail vehicle, the skid monitoring unit can monitor in real time whether the running wheels of the rail vehicle are slipping. When the skid monitoring unit detects the skid of the rail vehicle, the voltage or current of the electromagnetic coil is controlled to increase. In this way, the friction between the running wheels and the metal track beam can be increased to reduce the degree of skidding of the running wheels on the metal track beam, thereby reducing the wear of the running wheels.

　　BYD applies for optical structure, end point shell and end point patent, patented technology can make pattern formation have three-dimensional effect

　　According to the announcement of the State Intellectual Property Office, the BYD joint stock company applied for a project called "optical structure, end point shell and end point", public number CN117677087A, and the application date is August 2022.

　　The patent abstract shows that this application provides an optical structure, an end point housing, and an end point. The optical structure includes a substrate layer, a pattern layer, and a microlens layer. The substrate layer includes opposing first and second surfaces. The pattern layer is arranged on the first surface of the substrate layer. The pattern layer includes a plurality of pattern units arranged in an array, and each pattern unit is part of a preset pattern. The microlens layer is arranged on the second surface of the substrate layer. The microlens layer includes a plurality of microlenses arranged in an array. Each microlens corresponds to a pattern unit, and each pattern unit is located within the projection of the corresponding microlens on the pattern layer. Wherein, the plurality of microlenses are used to cause the plurality of pattern units to form a preset pattern with a stereoscopic effect. The present application provides an optical structure, the end point of the housing and the end point, by each pattern unit in the pattern layer is provided as part of a predetermined pattern, so that a predetermined pattern having a stereoscopic effect can be formed by a plurality of microlenses.

　　BYD applies for a battery preparation system patent to improve battery preparation efficiency

　　According to the announcement of the State Intellectual Property Office, BYD’s joint stock company applied for a project entitled "Cell Preparation System, Cell Preparation Method, Laminated Cell and Battery", public number CN117673427A, and the application date is August 2022.

　　The patent abstract shows that the present invention provides a battery cell preparation system, a battery cell preparation method, a laminated battery cell and a battery. The battery cell preparation system includes a handling mechanism, a positioning member, a roller set for transporting the diaphragm, and a laminating stage disposed below the roller set. The diaphragm is partially laid on the laminating stage, and the diaphragm can be folded when the laminating stage is switched between the first laminating position and the second laminating position. The handling mechanism is used for transporting the first pole piece to the diaphragm above the laminating stage laminated in the first laminating position, and for transporting the second pole piece to the diaphragm above the laminating stage laminated in the second laminating position. The positioning member can be moved between the first auxiliary position and the second auxiliary position, and the positioning members located in either auxiliary position are bonded to the surface of the diaphragm facing away from the lamination stage from one side of the diaphragm in the width direction to the other side. It is used to fix the lamination stage relative to the lamination stage to support the diaphragm during the lamination position switching process of the lamination stage, and move to the corresponding auxiliary position when the lamination stage completes the lamination position switching and the diaphragm is laminated with a first pole piece or a second pole piece.

　　BYD applied for a patent for the control method, system, storage medium and target controller of the logic section, which increased the flexibility of manual path selection and greatly improved the dispatching efficiency

　　According to the announcement of the State Intellectual Property Office, BYD joint stock company applied for a "control method, system, storage medium and target controller of logical section", public number CN117657259A, and the application date is August 2022.

　　The patent abstract shows that the present disclosure relates to a control method, system, storage medium and target controller of a logical section. By acquiring a section control instruction triggered by a dispatcher through the automatic vehicle monitoring system ATS, the section control instruction includes the dispatcher. The ATS selects a target logical section from a plurality of preset logical sections, and the section control instruction is used to instruct the corresponding section path of the target logical section as an artificial path, or to instruct to cancel the section path as the artificial path. According to the section control instruction, section control is performed on the target logical section; the method can use the selected logical section as an artificial path, and no longer rely on the position of the signal to determine the manual path. In this way, the flexibility of manual path selection is increased, and the scheduling efficiency is greatly improved.

　　BYD applies for a patent for bogies and rail vehicles, which can enhance the riding experience for those located inside the vehicle

　　According to the announcement of the State Intellectual Property Office, BYD’s joint stock company applied for a project called "Bogies and Rail Vehicles", public number CN117657234A, and the application date is August 2022.

　　The patent abstract shows that this application discloses a bogie and a rail vehicle. The bogie includes a shaft bridge, a first elastic member, a second elastic member, a first support frame and a second support frame; the lower ends of the two elastic members are connected to the shaft bridge; the first support frame is used to fix the vehicle body connected to the rail vehicle; the second support frame is connected to the upper ends of the two elastic members, and the second support frame is rotatably connected to the first support frame. Thereby, the first support frame is used for connecting to the vehicle body, the second support frame is connected to the upper ends of the two elastic members, the lower ends of the two elastic members are connected to the shaft bridge, and the first support frame is rotatably connected to the second support frame. In this way, when the rail vehicle provided with the bogie travels in the extending direction of the track beam, if there is a difference in the height position of the two running surfaces of the track beam, the vehicle body swings about the rotation axis of the first support frame and the second support frame, and the vehicle body swings with less freedom, which can improve the riding experience of the person located in the vehicle body.

　　BYD applies for an information processing patent to achieve the effect of non-sensory parking for vehicles

　　According to the announcement of the State Intellectual Property Office, the BYD joint stock company applied for an application entitled "Information Processing Method, Server, Parking Method, Parking System and Vehicle", public number CN117671989A, and the application date is August 2022.

　　The patent abstract shows that the present application relates to an information processing method, which is applied to a server, comprising: acquiring parking information of a plurality of vehicles, wherein the parking information of each vehicle includes the vehicle position and the vehicle attitude of the vehicle parking; determining the parking position and the direction of the parking space based on the parking information; determining the usable parking space based on the parking position and the direction of the parking space; obtaining a parking space map including the usable parking space according to the available parking space. Through the information processing method applied to the server by the present application, it is possible to expand the search range of the parking space, and recommend a parking space with a high confidence level for the vehicle, thereby realizing the non-sensory parking effect of the vehicle. The present application also provides a vehicle, an information processing method applied to the vehicle, a parking system and a parking method applied to the parking system.

　　BYD patented identification method for display devices to improve system start-up efficiency

　　According to the announcement of the State Intellectual Property Office, the BYD joint stock company applied for a "identification method, device, medium, display system and vehicle of display equipment", public number CN117676157A, and the application date is August 2022.

　　The patent abstract shows that the present disclosure relates to an identification method, device, medium, display system and vehicle of a display device to improve system start-up efficiency. Applied to a controller, the controller is connected to at least one display device, and each said display device is provided with a memory for storing a device code of the display device; the method comprises: establishing a communication connection with a target display device to be identified, and the target display device is one of the at least one display device; after the communication connection is successfully established, access the memory of the target display device through the target memory address to read the device code stored in the memory; determine the model of the target display device based on the read device code.

　　BYD applies for a patent for rotary components to improve the safety and service life of rotary components

　　According to the announcement of the State Intellectual Property Office, BYD’s joint stock company applied for a project entitled "Rotary components and motor components, electric assemblies and vehicles with them", public number CN117672662A, and the application date is August 2022.

　　The patent summary shows that the present invention discloses a swirl assembly and a motor assembly, an electric motor assembly and a vehicle having the same, the swirl assembly comprising: a primary housing, the primary housing is provided with a primary winding; a secondary housing, one end surface of the secondary housing in the axial direction is directly opposite the primary housing, a secondary winding is provided in the secondary housing, and the secondary housing is facing away from the primary housing. A first annular wall is formed on the other end surface, and a balance hole is formed inside or on the surface of the first annular wall. The swirling component of the present invention fully considers the dynamic balance problem during the high-speed rotation of the secondary winding during the design process, and the balance hole on the secondary side casing can reduce the weight of the secondary side casing, so as to maintain the quality distribution of the secondary side casing. Uniformity, reduce the failure rate of the swirling component, and improve the safety and service life of the swirling component.

　　() Apply for a patent for monodisperse magnetic nanoparticles and their preparation method, and prepare magnetic nanoparticles with basically the same morphology and controllable particle size

　　According to the announcement of the State Intellectual Property Office, Guangzhou Da’an Gene joint stock company applied for a project called "a monodisperse magnetic nanoparticle and its preparation method", public number CN117658224A, and the application date is August 2022.

　　The patent abstract shows that the embodiment of the present application belongs to the technical field of magnetic nanomaterials, and relates to a monodisperse magnetic nanoparticle and a preparation method thereof, including adding a weakly basic salt and polyethylene glycol to ethylene glycol, mixing uniformly to obtain A liquid; dissolving a soluble iron salt in ethylene glycol to obtain B liquid; mixing A liquid and B liquid and performing ultrasonic operation to obtain a precursor liquid; heating the precursor liquid, cooling the reaction product to room temperature, pouring out the supernatant to obtain the reaction product; washing and drying the reaction product to obtain the magnetic nanoparticle. The present application can achieve the purpose of regulating the particle size of the product, and preparing the magnetic nanoparticle with a substantially uniform morphology and controllable particle size. At the same time, the preparation method is simple and reliable, and mass production can be achieved.

　　() Apply for a patent for a four-way valve and air conditioning equipment to solve the problem of refrigerant backflow in the refrigerant system, thereby improving the lifespan of the refrigerant circulation system

　　According to the announcement of the State Intellectual Property Office, Zhejiang Dunan artificial environment joint stock company applied for a project called "four-way valve and air conditioning equipment", public number CN117662804A, and the application date is August 2022.

　　The patent abstract shows that the present application relates to the technical field of heat exchange, in particular to a four-way valve and air conditioning equipment. In particular, the four-way valve provided by the present application includes a first nozzle and a main valve body. The first nozzle is used to connect the exhaust port of the compressor. The main valve body is provided with a valve cavity, and the first nozzle is connected to the main valve body and connected to the valve cavity. The valve cavity is provided with a flow blocking structure. When the refrigerant flows from the first nozzle to the valve cavity, the refrigerant can push the flow blocking structure to move in a direction away from the first nozzle so that the first nozzle communicates with the valve cavity. When the refrigerant has a tendency to flow from the valve cavity to the first nozzle, the refrigerant can push the flow blocking structure to move in a direction close to the first nozzle to cut off the first nozzle and the valve The four-way valve provided herein solves the problem of refrigerant backflow in a refrigerant system, thereby increasing the life of the refrigerant circulation system.

　　TCL Technology applies for a patent for the preparation method of side electrodes, which is conducive to the development of narrow-bezel or even bezel-less panels

　　According to the announcement of the State Intellectual Property Office, the () group joint stock company applied for a project entitled "Side electrode preparation method, substrate with side electrode, electrode and display panel", public number CN117672963A, and the application date is August 2022.

　　The patent abstract shows that the present application discloses a method for preparing side electrodes, a substrate with side electrodes, electrodes, and a display panel. The side surface of the first substrate of the present application includes a transition surface, and the side surface is connected to the first surface through the transition surface. The transition surface includes at least one of a plane and a curved surface. In this way, the side electrode can be effectively prevented from falling off, and an adhesive layer is provided between the first substrate and the side electrode, which can improve the adhesion of the side electrode process, improve the yield, and facilitate the development of narrow-bezel or even bezel-free panels.

　　BYD Semiconductor applies for an overcurrent protection circuit patent, which can avoid frequent circuit disconnection affecting the use of power devices

　　According to the announcement of the State Intellectual Property Office, BYD Semiconductor joint stock company applied for an application entitled "An overcurrent protection circuit and a control method based on overcurrent protection circuit", public number CN117674788A, and the application date is August 2022.

　　The patent abstract shows that the present invention provides an overcurrent protection circuit and a control method based on the overcurrent protection circuit. The overcurrent protection circuit includes a comparator and a signal modifier, and the output end of the comparator is connected to the input end of the signal modifier; the input end of the comparator is connected to the current output end of the switching component in the power device; and the output end of the signal modifier is connected to the switching control end of the switching component. Through the embodiment of the present invention, the overcurrent protection of the power device is realized by modifying the control signal of the switching component, without completely disconnecting the circuit and then manually resetting, avoiding frequent disconnection of the circuit affecting the use of the power device, and enabling All cases where the current is too large are treated with overcurrent protection, which avoids damage to the power device due to the absence of overcurrent protection treatment due to the presence of some cases where the current is too large.

Geely × Aerospace, satellite communication technology takes the lead in ＂getting on the bus＂

With the continuous breakthrough of science and technology, the era of satellite communication has been gradually unveiled.

At 7:37 on February 3, 2024, the second orbital plane of the Geely Future Travel Constellation was successfully launched from the Xichang Satellite Launch Center in a one-shot 11-star manner, setting a new record for the number of satellites launched at the launch site.

According to public information, Geely Future Travel Constellation is the world’s first commercial communication, navigation and remote sensing integrated constellation built by Spacetime Daoyu. The first orbital plane of its predecessor has successfully completed a series of work such as satellite mass production, orbital plane-level deployment, constellation-level measurement and control, and application testing; now the second orbital plane has also been successfully launched. In the future, Spacetime Daoyu will empower the "ground" with "aerospace" to provide high-reliability and low-cost application services in satellite communication, autonomous driving, and intelligent networking.

Communication technology welcomes key breakthroughs

"In the past 30 years, every technological iteration in the information and communication industry has brought about changes in lifestyle. But in fact, from 2G, 3G, 4G to the current 5G, about 70% of the space on our planet is still not covered by ground network signals. The integration of heaven and earth has brought more imagination to intelligent network connection and autonomous driving in the continuous iteration of the information and communication industry from 5G to 6G." Wang Yang, CEO and chief systems engineering expert of TikTok, once said why he wants to enter satellite communication technology.

As Wang Yang said, the field of communication has undergone tremendous changes in recent years, but the exploration of communication technology is still accelerating. According to MIIT’s previous disclosure, China will accelerate the development and innovation of 6G technology and achieve commercial use around 2030.

There is a core technology that needs to be overcome between the current 5G and 6G applications – the "heaven and earth integrated" communication network. When the satellite Internet and the ground communication network are fully integrated determines when we can truly enter the 6G era.

In order to promote the rapid development of satellite communication technology, on April 20, 2020, the National Development and Reform Commission listed satellite Internet as a "new infrastructure" for the first time, and the prelude to the "Star Age" of big communication began.

In the face of new trends, Geely Group’s commercial aerospace technology enterprise Spacetime Daoyu began to independently develop the "Geely Future Travel Constellation" satellite, striving to achieve centimeter-level high-precision positioning, including autonomous driving navigation, broadband Internet access and other services, through satellite communication to change the car life.

On June 2, 2022, Geely Holding Group successfully launched the first batch of nine small satellites, all of which successfully entered the predetermined orbit. At that time, Geely said:The satellite project is a typical example of Geely’s "new infrastructure" investment. It not only provides infrastructure for Geely’s own integrated travel ecosystem, but also provides support for future travel, intelligent manufacturing, drone transportation, urban management and other fields, and builds a technological ecological chain advantage.

Wang Yang said: "Geely has changed from a simple car manufacturer to a comprehensive travel service provider. The satellite information and communication industry has actually spanned industrial production, consumer services and other fields. Geely’s layout in commercial aerospace, including a new generation of low-orbit satellite service networks, is an inevitable trend."

Satellite communication technology on board

It is worth noting that the current "Geely Future Travel Constellation" has been successfully implemented.

In September 2023, Time and Space Daoyu undertook the important task of "Asian Games Intelligent Guarantee", and successfully guaranteed the travel safety of nearly 2,000 officially designated vehicles of the Asian Games for a total of 36 days 7 × 24 hours a day. Finally, relying on high-precision positioning services, all vehicles are running stably online, and the driving routes cover the host city Hangzhou, as well as the five co-host cities of Ningbo, Wenzhou, Huzhou, Shaoxing and Jinhua. As of 24:00 on October 8, the accumulated guaranteed mileage is about 1.585 million kilometers.

On October 27, 2023, aerospace products were put into production for the first time at the vehicle level – Krypton officially released the pure electric hunting supercar Krypton 001 FR, which realized the on-board satellite communication function through cooperation with Spacetime Daoyu.

Through equipped with space-time Daoyu self-developed vehicle satellite communication end point – Ji Shi Xun ?, with vehicle satellite communication antenna and software services,In the absence of a terrestrial network or damage to the terrestrial network, users can make and receive satellite calls and send and receive satellite messages using the Krypton 001 FR vehicle system. In addition, in the event of a car collision, excessive carbon dioxide concentration in the vehicle, or thermal runaway of the battery, the vehicle can achieve autonomous alarms through satellites, which greatly enhances the driving safety of the vehicle.

In addition, Spacetime Daoyu also took the lead in the establishment of vehicle-mounted satellite Internet industry standards, led the completion of the first domestic research project for the construction of vehicle-mounted satellite communication industry standards, and joined forces with polar krypton and other partners to complete the "General Specification for Satellite Communication Vehicle End Point" standard project, "Consumer End Point Technical Requirements and Test Methods to Support Low-Orbit Satellites" standard exposure draft, which promoted the standardization and standardization of the industry.

Based on the current achievements, Space-Time Daoyu will complete the deployment of 72 satellites in the first phase of the constellation within two years to achieve global real-time data communication services; the second phase will expand to 168 satellites to achieve global centimeter-level high-precision positioning services… Through the deep integration of aerospace technology and new energy technologies, Space-Time Daoyu will continue to explore the highly coordinated development of the commercial aerospace industry and the intelligent pure electric vehicle industry, using automobiles as anchors to find new blue oceans.

Autonavi Space-Time Map： Linking Everything About Travel

Recently, the Verge, a well-known foreign technology media, launched an interesting survey to ask people how many apps they have installed on their mobile phones.

Most people’s answers ranged from dozens to hundreds, but there was an extreme "cultivator" in the answer, claiming that he did not install a third-party APP, and that communication, payment, and email were all using the APP that came with the mobile phone.
This conclusion sounds incredible, but it may not be nonsense.
After all, GMS and iOS bring-your-own services are really manageable for many foreigners without the bells and whistles; and their daily use of smartphones is far less "far ahead" than ours.
Without installing a third-party APP, it would definitely not work in China, and a WeChat could not be bypassed. However, from another perspective, a WeChat could be everything for many people, capable of covering almost all their needs… Even Douyin, who was at the height of the sun, could use WeChat Channels to replace it.
Especially with the Mini Program, a universal system, if you don’t consider the experience and/or some heavy vertical requirements (such as 3A game masterpieces), you can really live with WeChat in China.
Therefore, it has been said for a long time that WeChat is not an application, but an operating system.

But there is one type of service that WeChat has yet to handle.

On WeChat, you can still know where you are or where you want to go in various ways, because WeChat can call the map through the interface; but if you decide to leave, the above picture will appear, which cannot be avoided.
Navigation may be the most special kind of app, because it must be strongly related to time and space: where you are, where you go, and how you get there. The core variable is "positioning", and WeChat can be used even if the positioning is turned off; but without answering the above three questions, navigation has no meaning.
This may also be the core reason why Autonavi claims that the latest version is a "space-time map".
WeChat or most other applications essentially consume information and content services, and a lot of computing takes place before consumption. In order to get the best results, users will only see whether the results are good or not (such as whether the searched articles are good or not, and whether the recommended products meet the needs). Of course, people who use Autonavi also value the results. Navigation to the destination and destination-based services are the core, but they also value the process – they are all driving home, driving all the way and detouring because of traffic jams. Half a life is obviously much worse.
Due to this, Autonavi’s location perception and calculation not only occurs in front of the line, but also in the line (traffic conditions change rapidly). It needs to directly or indirectly "locate" to link everything related to travel in real space in real time: traffic lights, intersections, tunnels/viaducts, congestion conditions, lanes, obstacles, and even the shadow area of trees and buildings; in addition to space, it also needs to compare historical data across time to obtain future trend predictions, and timely prompt or guide users.
To perform this kind of real-time, large-scale computing requires extremely strong information links and underlying technical capabilities, which is why Autonavi must essentially be a technology company.

It can be said that Autonavi is essentially an enterprise based on the "space-time interconnection", and it was not until the latest release of v13 that the name "space-time map" was implemented, perhaps because the ability to perceive and calculate on a large scale has reached a qualitative change node.

The newly released Wonderland MAX, a neural rendering technology based on deep neural networks and physics engines, helps users get a bird’s-eye view of the scene stereo model from multiple time periods and directions, so as to feel the immersive "sense of place" across time and space, and even further understand the more detailed introduction and consumption information of the destination, which is to give users better travel results.
Autonavi Space-Time Map: Linking Everything About Travel
There are also blind spot meeting warnings based on the Beidou system, Beidou lane-level navigation 2.0, tunnel navigation, elevated navigation, and parking space navigation for special travel scenarios, as well as along-the-way search services, all of which are connected to more physical details and elements in the real world, continuously carry out real-time large-scale interactive computing, and deduce the optimal travel solution at the time and space level, essentially for a better travel process.
The results and process are both great, and naturally more people will be willing to use Autonavi.
People are nothing more than two states, either staying in the same place or on the road.
Autonavi Space-Time Map: Linking Everything About Travel

Autonavi Space-Time Map: Linking Everything About Travel

Autonavi Space-Time Map: Linking Everything About Travel
WeChat is undoubtedly a very powerful application, almost representing the ultimate form of static consumption of information and content. A person with a mobile phone and a WeChat, finding a place to sit, is enough to satisfy most of your imagination of the mobile Internet.
"I can do this all day."
But WeChat doesn’t do it all. Because people are in different states when using Autonavi, the current time-space transfer is another dynamic dimension of the ability: find a good place that suits you best, and then escort you to navigate in the most time-saving and labor-saving way.
Staying is important, but there are many good things when you go out.

Leifeng network(Official account: Leifeng.com)

Leifeng.com copyright article, unauthorized reprinting is prohibited. For details, please refer to the reprinting instructions.

Meituan will turn from profit to loss in 2021, with higher expenses such as rider costs and R & D expenses

In the post-epidemic era, Meituan (3690.HK) revenue has risen steadily. On March 25, Meituan released the fourth quarter and full year results of 2021. In 2021, the company’s revenue was 179.128 billion yuan (RMB, the same below), an increase of 56% year-on-year; the company lost 23.536 billion yuan during the year and 4.708 billion yuan in profit in the same period last year; the company’s adjusted net loss was 15.572 billion yuan, and the profit in the same period last year was 3.121 billion yuan.

　

Food and beverage takeaway is an important revenue business of Meituan, and the operating profit of this business in 2021 is 6.175 billion yuan; however, the policy requirements of "reasonable reduction of merchant service fees" and the corporate responsibility to improve the protection of riders’ rights and interests have also increased Meituan’s operating costs. The restaurant and wine travel business is a major source of profit for Meituan. In 2021, the operating profit of this business is 14.20 billion yuan.

　

However, the operating profits of the above two major businesses cannot offset the losses caused by the expansion of Meituan’s new business. Meituan’s new business, which mainly focuses on community group buying, shared travel, and instant shopping, has an operating loss of 38.40 billion yuan in 2021. At the same time, Meituan also continues to increase the company’s R & D investment, and the R & D expenditure in 2021 will reach 16.70 billion yuan.

　

2021 was an extraordinary year for Meituan, with the company’s performance turning from profit to loss. At the same time, Meituan’s anti-monopoly penalty was also settled and fined 3.442 billion yuan. Affected by policies and the general environment, Meituan’s share price declined as a whole in 2021, peaking at HK $460/share that year, and then fell below HK $300/share twice in July and November of that year. On December 31, 2021, it closed at HK $225.4/share. As of the close on March 25, Meituan closed at HK $135/share, down 8.16%.

　

"In 2021, despite the impact of the epidemic, we will still overcome difficulties and strive to provide hundreds of millions of consumers with reliable and convenient life services, help merchants use digital means to expand online operations, and help more entrepreneurs and employees achieve stable income," said Wang Xing, CEO of Meituan. "Meituan will unswervingly fulfill its platform responsibilities, unswervingly increase investment in technology, unswervingly continue to expand its business, and focus on the’retail + technology ‘strategy to deepen the Chinese market and create more value for merchants, users, riders and other ecological partners."

　

The profit of catering takeaway operation is 6.175 billion yuan, which enhances the protection of riders’ rights and interests

　

Under the pressure of repeated epidemics, Meituan’s food and beverage takeaway business continued to grow. The number of annual transaction users and the per capita transaction frequency in 2021 reached a record high. The peak of single-day orders broke through 50 million in August 2021 and reached a new high in December of that year. The number of transactions in the whole year reached 14.40 billion, an increase of 41.6% year-on-year.

　

In 2021, Meituan’s catering takeaway business will see significant growth in categories such as nighttime, milk tea, salad and light food. Supply growth effectively drove an increase in orders from medium and high-frequency users. Therefore, the number of annual transaction users of catering takeaway increased by 13% year-on-year, and the average transaction frequency of annual transaction users increased by 25% year-on-year.

　

In 2021, Meituan’s catering takeaway business transaction amount was 702.10 billion yuan, an increase of 43.6% year-on-year; revenue was 96.30 billion yuan, an increase of 45.3% year-on-year. Operating profit increased from 2.833 billion yuan in 2020 to 6.175 billion yuan in 2021, while operating profit margin increased from 4.3% to 6.4%.

　

The topic of takeaway merchant commissions has attracted much attention. In 2021, Meituan takeaway’s commission income (technical service fee) obtained through merchants was 28.547 billion yuan, 18.503 billion yuan in the same period of the previous year, an increase of 54.3% year-on-year; compared with the company’s catering takeaway transaction amount in 2021, the takeaway platform commission rate was about 4.1%.

　

However, the 2021 government work report proposed to "guide platform enterprises to reasonably reduce merchant service fees." Subsequently, the National Development and Reform Commission and other departments also issued the "Implementation Plan for Accelerating the Cultivation of New Consumption", proposing to guide online platforms such as takeout to rationally optimize the use of small and medium-sized enterprises. Merchants and individuals use the platform to operate commissions, commissions and other expenses, and use technology to empower operators to reduce costs and increase efficiency within the platform.

　

In 2021, Meituan takeaway and other platforms took the initiative to optimize the platform charging model and implement a pilot "rate transparency". At the same time, the protection of rider rights and interests is also a major responsibility of Meituan. In July of that year, Meituan established a takeaway rider service department. In 2021, Meituan held 136 rider talks.

　

The financial report shows that the vast majority of Meituan takeaway’s total revenue is rider delivery costs. In 2021, there are about 5.27 million riders who earn income on the Meituan platform. Meituan takeaway rider delivery costs were 68.183 billion, an increase of 38.3% year-on-year, accounting for 71% of Meituan’s total takeaway revenue.

　

In addition, the breakdown data of the financial report shows that in 2021, Meituan’s food and beverage distribution service revenue collected from merchants and users was 54.204 billion yuan, while the annual rider delivery cost was 68.183 billion yuan. The above data shows that Meituan’s annual direct subsidy for riders cost nearly 14 billion yuan.

　

The operating profit of the hotel is 14.20 billion yuan, and the operating loss of the new business is 38.40 billion yuan

　

In the post-epidemic era, Meituan’s store, hotel and tourism business has achieved steady growth. In 2021, Meituan’s store, hotel and tourism business revenue was 32.50 billion yuan, an increase of 53.1% year-on-year; operating profit increased from 8.181 billion yuan in 2020 to 14.193 billion yuan in 2021, while operating profit margin increased from 38.5% to 43.3%.

　

According to the financial report, Meituan’s 2021 store-to-store business transactions, transaction amounts and annual active merchants all hit record highs. Meituan has strengthened its penetration into lower-tier cities across the country. Categories such as leisure entertainment, fitness, elderly care services, medical care and pet services are growing strongly; while categories such as manual activities, recording studios, light and shadow interactive halls, and stress relief experience halls have become new consumer trends.

　

In terms of hotels and tourism, the number of hotel room nights in China will increase by 34.5% in 2021. In addition, Meituan has consolidated its competitive advantage in the low-star hotel sector, diverting offline users to online platforms to help more hotel merchants operate digitally. In the high-star hotel sector, high-star hotel room nights will account for more than 16.5% in 2021.

　

In 2021, Meituan continued to expand its investment in new businesses, especially commodity retail. In 2021, Meituan’s new business and other business revenue was 50.30 billion yuan, an increase of 84.4% year-on-year. The operating loss expanded from 10.90 billion yuan in 2020 to 38.40 billion yuan in 2021, and the operating loss ratio increased by 36.6 percentage points year-on-year.

　

Community group buying is the exploration direction of Meituan’s new business. In the second half of 2020, community group buying began a new round of industry competition. At that time, Internet companies such as Didi, Meituan, Pinduoduo, JD.com and others invested in the ante one after another. However, with the development of policies and markets, the community group buying industry will experience ups and downs in 2021. Orange Heart is preferred to face business shrinkage, and Jingxi is also reported to reduce staff and withdraw from the city.

　

At present, Meituan Preferred is relatively stable. According to the financial report, Meituan Preferred has achieved healthy growth thanks to clear policy guidance and a good market competition environment. The "next day pick-up" three-tier warehouse distribution logistics network system has covered most communities and rural areas in 30 provinces across the country. In the future, strict compliance with regulatory regulations will be the top priority, and we will continue to focus on balanced and high-quality growth.

　

Meituan flash sale exceeded 6.30 million in single-day orders in December 2021. On the supply side, it has expanded its product categories and established cooperation with more high-quality local stores. Flowers, supermarkets and convenience stores continue to maintain a high growth momentum. At the beginning of this year, 24-hour drug delivery service was launched. In 2021, Meituan market users and transaction amounts continue to increase.

High revenue and high investment, R & D expenses of 16.70 billion yuan

　

High revenue and high expenditure are the characteristics of Meituan’s performance in 2021. The company’s revenue hit a record high, and the operating profit turned from profit to loss, which also laid the foundation for future sustainable development to a certain extent. According to the financial report, Meituan’s R & D expenditure increased from 10.90 billion yuan in 2020 to 16.70 billion yuan in 2021, an increase of 53.1% year-on-year. The increase in employee welfare expenses was mainly due to business expansion.

　

On the other hand, Meituan has also increased investment in unmanned logistics research and development. Meituan drone has been in normal trial operation in Shenzhen for nearly a year, and has covered more than 8,000 households so far, completing 30,000 orders for real users. Meituan City Low-altitude Logistics Operation Demonstration Center has landed in Shanghai and will gradually cover the "3 km 15 minutes" low-altitude smart logistics network in East China.

　

In addition, Meituan automatic delivery has launched a low-speed instant delivery solution for outdoor scenes. As of December 2021, Meituan automatic delivery vehicle service has expanded to 20 communities in Shunyi District, Beijing, delivering nearly 190,000 orders, autonomous driving mileage over 700,000 kilometers, and daily delivery of more than 1,000 orders.

　

At the same time, the company’s overall operating costs also increased significantly. The cost of sales increased by 69.2% from 80.70 billion yuan in 2020 to 136.70 billion yuan in 2021, while the percentage of revenue increased by 6.0 percentage points to 76.3% year-on-year from 70.3%. The main reason is the increase in food delivery related costs, as well as the development and exploration of retail business and other new businesses.

　

In addition, the company’s sales and marketing expenses increased by 94.8% from $20.90 billion in 2020 to $40.70 billion in 2021, while the percentage of revenue increased by 4.5 percentage points year-on-year from 18.2% to 22.7%. Mainly due to the increase in promotion, advertising and user incentive expenses and employee benefits expenses. In addition, more employees were recruited to support the rapid growth of new businesses.

　

"Meituan’s development is closely related to the general environment of China’s economy, and it is also inseparable from the joint efforts of small and medium-sized businesses and related workers such as riders. We will continue to take high-quality and sustainable development as the company’s goal, and strive to drive consumption and industry transformation and upgrading, so that all relevant parties can benefit from it." Chen Shaohui, Meituan CFO, said: "Meituan will make long-term investment around the strategy of’retail + technology ‘, and through innovation and technology-driven, help more entrepreneurs and employees share the dividends of the digital economy."

　

Beijing News Shell Financial Reporter, Chen Weicheng, Editor, Song Yuting, Proofreader, Lu Qian

Sunset and Lonely Autumn Waters in Qi Fei —— Experience of Ecological Restoration Project in Wuliangsuhai Basin, Inner Mongolia

　　editorial comment/note

　　On average, 50 or 60 new cars are listed together every month, new energy vehicles are gradually becoming the main theme, and the market share of China brand passenger cars is stable at more than 50% … There are many bright spots in the automobile market in the first half of the year. Among these dazzling new cars, China brand, with its faster technical iteration, newer technical breakthrough and stronger power blessing, has set off a wave of innovation in the automobile industry, which not only ignited the enthusiasm of automobile market consumption, but also led the global era of new energy for automobiles.

　　Look up at U8

　　As one of the most dazzling star models in the first half of this year, it is impressive to look up to U8′ s powerful product strength and worth over one million yuan.

　　Looking up at the front face of U8, the design language of "dimension door" is adopted, with high recognition and square overall shape, showing a full-fledged hard-core cross-country style. The closed middle net and "Ding"-shaped light belts on both sides are more sci-fi, the interior has been redesigned, and the flying wing cockpit outline is adopted. The larger vertical screen in the center also enhances the overall sense of science and technology.

　　Thanks to BYD’s easy-to-square platform, looking up at U8 can control the power output and rotation direction of four wheels independently, which not only takes three seconds to accelerate at zero speed, but also can realize difficult actions such as turning around in place, moving laterally, driving with flat tire and floating mode. With the support of Yunqi -P system, looking up at U8 can also effectively restrain the posture change of the car body, avoid the vehicle bumping damage caused by terrain, and let the vehicle pass in the most stable and comfortable posture.

　　Zhiji LS7

　　Zhiji LS7 is the second model of Zhiji brand and the first medium-sized and large-sized pure electric SUV, which focuses on the "big five-seat" spatial layout and has a cruising range of 660 kilometers under CLTC working conditions.

　　The interior is undoubtedly one of the highlights of Zhiji LS7. The central control of the new car adopts the triple-screen design of "LCD instrument panel+central control screen+passenger display screen", in which the LCD instrument is integrated with the large LCD screen of the central control, and the huge screen with narrow frame also has the lifting function. The matching "semi-spoke steering wheel" and the embedded touch LCD display panel in the central channel area make this car full of scientific sense.

　　Driving quality is a commendable aspect of Zhiji LS7. As a big five-seat vehicle, Zhiji LS7 has made many upgrades in the ride comfort, equipped with zero-gravity floating seat, intelligent control full-flat folding co-pilot seat, super-long electric slide rail, etc., which can make the co-pilot slide and fold under the instrument panel, and provide two personalized functions of "zero-gravity mode" and "lying flat mode".

　　Geely Yinhe L7

　　No matter the urban roads, highways, provincial roads and country roads … Geely Yinhe L7 equipped with three intelligent electric technologies, namely "Aegis battery safety system, Raytheon hybrid 8848 and brand-new Yinhe N OS", has shown good strength and elegant demeanor.

　　It can be said that Geely has applied its latest and strongest technology to the Geely Galaxy L7, which is equipped with a Raytheon electric hybrid 8848 system consisting of a new generation of Raytheon electric hybrid engine and a new generation of Raytheon electric drive, and matched with a 3-speed variable frequency electric drive DHT Pro, with a comprehensive maximum power of 287kw and a comprehensive maximum torque of 535N·m, with the fastest acceleration of 6.9s km at the same level and the lowest power loss and fuel consumption of 5.23L/100km at CLTC.

　　At the same time, Geely Yinhe L7 has four driving modes: pure electric, extended range, intelligent and performance, among which the intelligent mode is the most worry-free, especially the 55-kilometer endurance version. The system will automatically determine the driver’s intention, and it can quickly switch between 20 working conditions such as series, parallel and series in 0.2 seconds to ensure good fuel economy and power level.

　　Galaxy L7 also shows the "safety" genes carved into Geely’s bones, from battery and intelligent architecture to vehicle safety and software intelligent control, and then to the global integration with the pile end and the cloud, building a global safety protection system for new energy vehicles.

　　The intelligent level of Yinhe L7 is also excellent. Thanks to Snapdragon 8155 chip, the startup, response speed and voice wake-up of Yinhe N OS system are very fast, and the communication between people and vehicles is very smooth.

　　Weilai brand new ES6

　　The new ES6 is based on the latest NT2.0 platform of Weilai, and adopts the second generation design language of Weilai, which integrates the sensor layout of watchtower with the roof. Compared with the previous generation, the new ES6 has a longer wheelbase, wider body and lower height, showing a more dynamic body posture. The interior adopts an open double-layer embracing design, and the renewable rattan wood and the hidden air outlet are integrated, which is very layered. For the first time, the speaker is made of exclusive customized acoustic fabric, which has good sound permeability.

?

　　Thanks to the new platform, the new ES6 is equipped with the Banyan 2.0.0 system, which brings more than 120 new functions and experience optimization. Based on Aquila Weilai extrasensory system and ADAM Weilai supercomputing platform, the new ES6 comes standard with 23 safety and driving assistance functions. In addition, through the self-developed ICC intelligent chassis domain controller and CDC dynamic suspension damping control system, the new ES6 can switch freely between sports and comfort.

　　Tucki G6

　　Tucki G6 is regarded by the industry as Xpeng Motors’s masterpiece, which integrates many new technologies, such as SEPA 2.0 global intelligent evolution architecture, integrated casting, 800V high-voltage SiC silicon carbide platform, CIB battery body integration and so on.

　　Tucki G6 can be said to be a car born for driving control. The short front/rear suspension design makes the G6 more flexible and greatly improves the handling stability. The only front and rear integrated aluminum die-casting body in China has higher integration and stability; The torsional stiffness of the car body is as high as 41600N·m；; The stronger body rigidity greatly improves the body support and deformation resistance when the vehicle turns, making the vehicle posture more stable and easier to control.

　　Intelligence is the proudest place of Tucki G6, which is equipped with a high-order intelligent assisted driving system XNGP, including a new generation of high-speed NGP, urban NGP, VPA-L parking lot memory parking and other functions. Especially in the driving process, Tucki G6 will also open the "God’s perspective". The ——XNet Deep Visual Neural Network, a new generation visual perception framework in Tucki, can fuse the data collected by multiple cameras in multiple frames before the time sequence, and output the 4D information of dynamic objects and the 3D information of static objects from a bird’s eye view, such as the size, distance, position, speed, behavior prediction, lane line and road edge position of vehicles and two-wheelers.

　　Deep blue S7

　　Deep Blue S7 is the second model of Deep Blue Automobile under Changan Automobile. It claims to have "five industry starters, two at the same level, 31 at the same level, and 62 at the same level."

　　Under the support of EPA1 platform, Deep Blue S7 combines the advantages of pure electricity and fuel, which not only has lower vehicle cost, but also solves various problems such as mileage anxiety and inconvenience in recharging of pure electric vehicles. Among them, the extended-range version of Deep Blue S7 has a super-long comprehensive cruising range of up to 1120km, which can meet the demand of long-distance travel, without looking for a charging station along the way, just refuel and leave. In addition, the technical team of Deep Blue Auto also found the "password" for the battery to heat up rapidly in extremely cold environment, which effectively solved the problem of power decline caused by battery performance attenuation in extremely cold environment. In terms of intelligence, Deep Blue S7 supports the sound zone isolation function to create a voice interaction scene, and users can edit interesting and personalized wake-up and response. In addition, the whole scene of the car’s screen is "visible and can be said", and the user can replace the finger touch screen operation with voice only, making the operation more convenient.

　　It is worth noting that Deep Blue S7 also pays great attention to the air health in the car. Its forest air purification system can monitor and display the air quality information in the car in real time, accurately know the surrounding air quality information, and automatically realize the air purification in the car by using high-efficiency filter and ion purification technology.

　　Extreme krypton x

　　Extreme Krypton X is the third car owned by Extreme Krypton. The design of the mecha wind is very chic, and the edges and corners are very sharp, which is full of strong fighting atmosphere.

　　The configuration of this car is very high. The entry-level model has 360-degree panoramic image, reversing side warning system, full-speed adaptive cruise, electric memory trunk, hidden door handle, AR-HUD, multi-color atmosphere lights and other functions. Among them, Extreme Krypton X is the only vehicle in the whole industry equipped with a car refrigerator capable of refrigerating at minus 15 degrees, which can realize triple temperature control modes of extreme freezing, refrigeration and heat preservation, with the temperature control range from minus 15 degrees to minus 50 degrees.

?

　　Thanks to the full empowerment of intelligent drive, Extreme Krypton X staged a real version of "Speed and Passion": on the four-wheel drive version with the best performance, Extreme Krypton X was equipped with a high-performance permanent magnet synchronous electric drive system, and the layout of the front and rear double motors provided a strong power guarantee for the whole vehicle. The zero-speed acceleration only took 3.7s, and its power performance was comparable to that of V6 twin-turbo engine, making Extreme Krypton X one of the fastest compact luxury cars ever.

　　Byd seagull

　　The stylish and tough appearance, the leading configuration performance at the same level, the endurance of 405km and the pre-sale price of the entry version of 78,800 yuan make BYD Seagull quite eye-catching in its class.

　　BYD Seagull is a brand-new small pure electric vehicle launched by BYD in the first half of the year, which has a more exquisite and compact body design. Although the body length is not long, the overall sense of movement is excellent. At the same time, Seagull’s interior design has not been weakened because of its size, and it is also equipped with a practical DiLink Zhilian system.

?

　　Although it is mainly used in the scooter market within 100,000 yuan, BYD Seagull is still equipped with a permanent magnet motor with a maximum power of 55kW(75Ps), which can provide a maximum torque of 135 N m. The batteries are divided into 30.08kWh and 38.88kWh, which can fully meet the needs of daily walking or short-distance travel.

　　Thanks to the technical empowerment of e-platform 3.0, BYD Seagull also has the exclusive safety body structure of pure trams, with high-strength steel in the body-in-white accounting for 61%, and hot-formed steel with tensile strength exceeding 1500MPa is used in key parts, which can provide the most direct safety protection for the occupants in the car.

　　Ideality L7

　　Ideal L7 is an upgraded model based on Li ONE. This car adopts five seats, and still implements the design concept of "second bedroom" in LI. It has two rows of space and comfort beyond D-class luxury cars, creating a spacious, comfortable and warm exclusive space experience for a family of three.

　　In terms of configuration, the ideal L7 has only two versions, Pro and Max, and the different versions are different between the intelligent cockpit and the intelligent driver assistance system. For example, in the intelligent cockpit, the Max version has a 15.7-inch rear roof entertainment screen than the Pro version, and the Max version uses two 8155 car chips, which can connect VR glasses and Nintendo Switch, and is more comprehensive in intelligent experience.

　　In terms of power, the ideal L7 adopts the extended-range power layout. The whole system consists of a 1.5T extended-range device and front and rear motors, which can provide the maximum power of 330kW(449Ps) and the maximum torque of 620N·m, and the maximum endurance of CLTC in extended-range mode can reach 1315km. In addition, the combination of a 42.8 kWh battery pack and a 65-liter fuel tank is equivalent to storing more than 200 kWh of electricity for the whole vehicle. With the external discharge of 3.5 kW, an outdoor "starry playground", an open "kitchen" and a "viewing restaurant" for the whole family can be created, and the "home" can be moved to the most beautiful scenery.

　　Haval Xiaolong MAX

　　Xiaolong MAX is regarded as Harvard’s desperate work of new energy. Its face value is deeply loved by young people. The interior is designed with triple screen, equipped with Snapdragon 8155 chip and a new generation of Coffee OS system, and its performance in intelligence is excellent.

?

　　Most importantly, Haval Xiaolong MAX is the first vehicle equipped with Hi4 intelligent electric hybrid four-wheel drive system, a new hybrid architecture of Great Wall. The biggest highlight of this system is the deep integration of hybrid and four-wheel drive. It is equipped with a 1.5L hybrid engine, front and rear dual motors and a DHT hybrid gearbox, which can realize "three engines and nine models" and has excellent multi-scene adaptability. The fuel consumption of four-wheel drive models has reached the level of two-wheel drive hybrid models. In addition, as a plug-in hybrid system, it also supports pure battery life of 105km(NEDC working condition), with an acceleration of 6.8s per 100 km, and its overall performance is balanced and comprehensive.

　　(This version of the manuscript was written by reporter Fu Yongcai)

BYD Qin L DM-i Beijing Auto Show is the world premiere： it will be listed in the second quarter of this year, and it is estimated that the sword finger will be sold at the intermediate level from 120,

At the 2024 Beijing Auto Show, Qin L DM-i, a new member of BYD Dynasty series, made its world premiere. The model is scheduled to be officially launched in the second quarter of this year, and the price is expected to start from 120,000 yuan.

BYD Qin L DM-i Beijing Auto Show is the world premiere: it will be listed in the second quarter of this year, and it is expected to start selling at 120,000 yuan.

Qin L has a body size of 4830mm×1900mm×1495mm and a wheelbase of 2790mm, and is positioned as an intermediate car. Its birth aims to fill the gap between Qin family (compact crown) and Han family (medium and large crown) in the matrix of dynasty cars. On the one hand, Qin L will jointly challenge the joint venture mid-size sedan market represented by Camry with Han, and on the other hand, build a large and small Qin combination with Qin PLUS, aiming at the A+ market.

Based on the development of BYD’s new generation plug-in hybrid vehicle platform, Qin L is committed to breaking the traditional concept of "high fuel consumption" of mid-size cars and establishing a new fashion of "big and economical" mid-size cars through technological innovation.

In terms of intelligent configuration, Qin L is equipped with DiLink intelligent cockpit system, including 15.6-inch adaptive rotating suspended Pad, car ETC, NFC digital key and full-scene intelligent voice. In addition, the vehicle is equipped with DiPilot intelligent driving assistance system, which covers adaptive cruise, intelligent navigation, emergency lane keeping assistance, blind spot monitoring and other functions to improve driving safety and convenience.

It is reported that Qin L will enter the market in the second quarter of this year, and the pre-sale price will start from 120,000 yuan.

Krypton 001 FR, the strongest pure electrode on the surface, is on the market, and the price starts at 769,000 yuan.

　　[October 27, 2023, Beijing] Today, Extreme Krypton Intelligent Technology officially released the pure electric hunting super run — — Krypton 001 FR, the official retail price starts at 76.9 yuan. Extreme Krypton 001 FR combines the performance of tens of millions of super-running, the extreme safety of "highway", the luxury and comfort of executive cars, the ability of off-road SUVs to get rid of difficulties, as well as the top intelligent cockpit and intelligent driving experience, the driving ability of F1 world champions, and the car satellite phone that never loses contact, which subverts the limits of traditional super-running and brings users real super-running in the era of intelligent electric power.

If the picture cannot be displayed, please refresh the page.

　　Pure electric hunting super running pole Krypton 001 FR official retail price

　　Users who decide before December 31st can not only enjoy the six-year or 150,000-kilometer vehicle warranty, three-power lifetime warranty, free data flow, free road rescue during the warranty period, and free 7kW smart home pile-filling package (50 meters), but also get a "Raikkonen model" worth 60,000 yuan, with the same adjustment and driving experience as the "F1 champion".

　　Extreme performance continues to evolve, with an acceleration of 2.02 seconds and a maximum horsepower of 1300 horses.

　　Since its debut, Krypton 001 FR has been launched with five core technologies in global mass production: the four-motor distributed electric drive launched in global mass production, the world’s first ZVC four-wheel torque vector control, the world’s first "dragonfly structure" middle-section integrated die casting, the world’s first 8295 intelligent cockpit computing platform and the world’s first mass production satellite communication technology, making it the strongest pure electricity on the surface in the era of intelligent electric power.

　　In just over a month, Krypton 001 FR once again subverted the limit and continued to evolve. Extreme krypton’s pursuit of the ultimate makes its acceleration from 2.07 seconds to 2.02 seconds, and it only takes 6.29 seconds to accelerate from 0 to 200km/h, which is more than half a second ahead of the tens of millions of super-runs. Under the continuous adjustment of the engineering team, the 001 FR has added a special "ejection mode", which makes its starting time 0.02 seconds faster than the normal acceleration. With it, the 001 FR straight-line racing can always be one step ahead of others.

If the picture cannot be displayed, please refresh the page.

　　The 0-200km/h acceleration of Krypton 001 FR takes only 6.29 seconds.

　　The intelligent drive evolution of Krypton 001 FR is not only an instantaneous explosion, but also a full-range high-energy power output. The "overclocking mode" developed by Krypton for 001 FR turns the "nitrogen acceleration" function in racing games into reality, making the maximum horsepower burst instantly. The power of overclocking mode is increased by 10% compared with that of standard mode at high speed, and it can be started at any time of acceleration, so that the extreme krypton 001 FR can maintain a strong explosive force during the whole acceleration, whether it is cornering acceleration or overtaking straight. After the overclocking mode was started in "Raikkonen mode", the maximum horsepower of Krypton 001 FR was also increased from 1,265 at the time of debut to an astonishing 1,300.

If the picture cannot be displayed, please refresh the page.

　　Relying on Raikkonen mode and overclocking mode, Krypton 001 FR racing shows full-range high energy.

　　Behind the extreme performance of Krypton 001 FR is the core technology of Krypton high-efficiency hard core. Extreme Krypton 001 FR is equipped with the world’s first mass-produced 800V high-voltage system of silicon carbide, and each motor is equipped with a silicon carbide electronic control module separately, which is stable, efficient and accurate in control. The combined output power of the four motors can reach up to 956kW, matching with the leading performance of 100kWh Kirin battery, and the maximum charging rate can reach 4C. It only takes 15 minutes to charge the battery from 10% to 80%. The discharge power of krypton 001 FR battery reaches megawatt level. At the same time, the "straight waterfall oil cooling technology" is used to dissipate heat for the motor, and the PTM 2.0 global thermal management system is used to dissipate heat for the battery. The powerful thermal management system allows the peak power of krypton 001 FR to be continuously output for 12 times without attenuation. After 8 consecutive times of uninterrupted acceleration from 0 to 100km/h, and then braking to 0, the internal temperature of the battery only increased by 3.6 degrees during the vehicle test.

　　It is not only the temperature, but also the strength of the Krypton 001 FR intelligent electric drive that keeps stable. Krypton uses a 249-meter-long high-strength carbon fiber material to cover the motor rotor, which is covered with 15 layers. The sleeve is only 1.1 mm thick and weighs only 88 grams. It can withstand more than 16 tons of tension at the highest speed. This is also the reason why the maximum speed of the rear double motor of Krypton 001 FR exceeds 20,000 rpm, and its high-speed performance can still explode to the maximum speed.

　　Extreme safety is the strongest confidence on the surface, delivering 160 thousand, the only zero spontaneous combustion in the industry

　　Delivered more than 160,000 units, the only zero spontaneous combustion record in the industry, and the safety limit of electric vehicles has been constantly refreshed. Safety is the core gene of krypton, and krypton safety is the foundation of extreme performance of krypton 001 FR. Extreme Krypton 001 FR has been specially upgraded on the basis of the technology of "Road Tankryon". In addition to the 720-degree omni-directional safety armor, the middle part of the body of Extreme Krypton 001 FR adopts the world’s first "dragonfly structure" middle-section integrated die casting, and the entire aluminum rear body is also manufactured by the world’s original "four-section" rear-end integrated die casting process to minimize the impact on the battery pack during collision. Inside the battery, Krypton 001 FR adopts the world’s first double-large-face liquid cooling technology, and the heat exchange area is four times larger than that of the traditional liquid-cooled battery pack at the bottom, which realizes the integration of three functions: cooling, heat insulation and structural strengthening, and adds code layer by layer to effectively eliminate fire hazards.

If the picture cannot be displayed, please refresh the page.

　　Extreme krypton safety comprehensive advanced

　　"Not afraid of collision and not catching fire" is only the basis of extreme krypton safety, and excellent control is the core of extreme krypton 001 FR safety. Relying on ZVC four-wheel torque vector control, Krypton 001 FR can not only realize the tank turning without picking the road, but also realize the high-speed turning of the track. In the track test, the speed of Bugatti crossing S-bend on dry ground is 80km/h; Sprinkling water in the same bend, extremely Krypton 001 FR can cross the S-bend at a high speed of 80km/h, with stable body and precise control. Based on this, Krypton has also brought the much-anticipated "drift mode", so that drivers can enjoy the exciting high-speed drift and cornering experience.

　　Excellent performance under extreme dynamics benefits from the perfect cooperation of top software and hardware. Krypton 001 FR has the world’s largest carbon fiber roof, which is 1.46m long and 1.16m wide, and weighs only 6.5kg, which is 65% lighter than the traditional glass roof and 67% stronger. In addition, the front lip, side skirt, tail and diffuser of Krypton 001 FR are all made of carbon fiber aerodynamic kits, which can reduce the overall weight by more than 17kg and increase the downforce by 178kg when the vehicle is driving at high speed. With the strong grip brought by high-performance tires with narrow front and wide back at the track level, you can always maintain the best "flying on the ground" posture no matter how fast you are. KW, the world’s top shock absorber brand, customized the shock absorber for the original factory of Krypton 001 FR, so that the vehicle can perfectly match different track characteristics and different driving styles, bringing a more pure dynamic texture. The original factory comes standard with AP Racing 10-piston forged aluminum brake calipers and racing car’s exclusive oversize Brembo carbon ceramic perforated brake disc, so that polar krypton 001 FR rushes into the two-second club, while the braking distance of 100-0km/h is only 33.4 meters, even if it is driven fiercely for a long time, it can maintain the best braking state.

If the picture cannot be displayed, please refresh the page.

　　Excellent control is the core of kryptonian security.

　　The global evolution Raikkonen model allows you to have the same driving experience as the F1 champion.

　　The evolution of krypton is always inseparable from the co-creation of users, and the evolution of krypton 001 FR ushered in the help of F1 world champion kimi raikkonen. As the first European car owner and the chief performance consultant of Krypton 001 FR, kimi raikkonen participated in the development and adjustment process of Krypton 001 FR, and constantly tapped the great potential of this performance beast. At the press conference, An Conghui, CEO of Extreme Smart Technology, and kimi raikkonen jointly started, and the world’s first world champion who used intelligent algorithms to write in the car — — Raikkonen model copies the experience and ability of F1 champion to all owners of Krypton 001 FR.

If the picture cannot be displayed, please refresh the page.

　　The experience and technology of F1 world champion Raikkonen will be perfectly integrated into krypton intelligent drive.

　　The rich track experience and skillful skills of F1 world champion are perfectly integrated into the intelligent drive system. Raikkonen mode not only brings the maximum horsepower increase of 1,300 horses to Krypton 001 FR, but also makes exclusive customized adjustments to nine parameters of Krypton 001 FR, giving users a real chance to have the same driving experience as F1 champion. The new model will be officially launched by OTA in the first quarter of next year after the winter test. In the future, the evolution of the extremely krypton intelligent drive system will also empower all extremely krypton 001 models to achieve advanced performance.

　　The 8295 intelligent cockpit computing platform, which was first launched and delivered in the global mass production of extreme intelligence.

　　As a hard-core technology-driven company, Krypton has the ultimate pursuit for every product. Extreme Krypton 001 FR not only has the ultimate safety and performance, but also completely subverts the industry’s cognition of super-running and high-performance vehicles. Extreme Krypton 001 FR is the first in global mass production and the first to deliver the 8295 intelligent cockpit computing platform, which is 2.2 times more powerful than the 8155 computing platform, and the graphics and video processing capacity is 2.7 times higher. Based on the 8295 computing platform, Krypton has created an exclusive intelligent space for pure electric supercar for 001 FR.

If the picture cannot be displayed, please refresh the page.

　　Krypton created the world’s first exclusive intelligent space for pure electric supercar for 001 FR.

　　The intelligent follow-up seat solves the problem that the traditional bucket racing seat sacrifices comfort for performance. Daily driving can provide 10 points and 6 massage functions, and the comfort is full. When driving fiercely, the seat will respond dynamically within 0.1 second according to the vehicle dynamics, increasing the lateral support of the waist and legs, so that the driver can realize the integration of people and vehicles in the most comfortable sitting position. In addition, Extreme Krypton 001 FR will also be equipped with a brand-new 2.5K flexible OLED central control panel, 35.5-inch super-large imaging HUD, competitive style instruments and atmosphere lights as standard; There is also the top Yamaha stereo, with a rated power of 2400 watts and 28 speakers in the whole car, so that each seat is 7.1.4-channel surround sound. Top-level full-featured attributes also satisfy the passion of track driving and the comfort of street commuting.

　　In addition to hardware, there is also a comprehensive upgrade of software. The full digital capability of the krypton intelligent drive system opens all the performance parameters of the krypton 001 FR. Extreme Krypton 001 FR matches the first built-in professional track APP in the history, which can make all four categories of performance parameters open, each item can be adjusted by more than 10 gears, and there are more than 13,000 custom driving styles. In addition, this track APP also has a perfect video recording function, which can perfectly restore the driver’s driving performance on the track and easily share it with other riders. It is a real track dating artifact.

　　In terms of intelligent driving that users pay attention to, Extreme Krypton 001 FR is also an intelligent pure electric supercar that can be equipped with laser radar, and has intelligent driving ability covering the whole scene of cities and high speed. Lu Yu extreme weather, strong perception can still better identify road conditions, both safe and worry-free. Even if we drive to no man’s land, the vehicle-mounted satellite communication technology, which was launched in the global mass production of Krypton 001 FR, can escort users and make safety never lose contact.

If the picture cannot be displayed, please refresh the page.

　　Krypton 001 FR is an intelligent pure electric supercar that can be equipped with laser radar.

　　Embracing the era of users, polar krypton provides sufficient choice space for car owners. All car owners of polar krypton 001 FR will have two kinds of car roofs for free: if you want to be extremely pure, you can choose the world’s largest carbon fiber car roof; If you want to be intelligent and advanced, you can choose lidar+intelligent light roof. No matter which roof you choose, the ZAD fully intelligent driver assistance system will be standard on the Krypton 001 FR, which will bring users an unprecedented leading intelligent experience in super-running.

　　Let the face value of hunting clothes, the performance of super-running, the comfort of cars, the space and ability of getting rid of difficulties of SUVs, and the top-level intelligent experience be met at the same time in one car. Get on the track, get off the street, and even pursue poetry and distance. Extreme Krypton 001 FR will be an all-round pure electric hunting supercar covering all road conditions and scenes.

If the picture cannot be displayed, please refresh the page.

　　Full road condition, full scene, all-round pure electric hunting super run

　　Eight hard-core technologies were launched in the global mass production, and six performance parameters ranked first in the global mass production, with over 100 luxury configurations as standard. Extremely, 001 FR once again subverted the tradition and opened the era of intelligent electric supercar. Whether it’s hunting coupe or hunting supercar, Krypton has always evolved in the spirit of pursuing the ultimate, setting a real value benchmark for users.

　　-End-